Design, synthesis and assembly of genetically engineered proteins : simple routes to biocatalytic surfaces. by Wu, Dong,
University of Massachusetts Amherst
ScholarWorks@UMass Amherst
Doctoral Dissertations 1896 - February 2014
1-1-1997
Design, synthesis and assembly of genetically
engineered proteins : simple routes to biocatalytic
surfaces.
Dong, Wu
University of Massachusetts Amherst
Follow this and additional works at: https://scholarworks.umass.edu/dissertations_1
This Open Access Dissertation is brought to you for free and open access by ScholarWorks@UMass Amherst. It has been accepted for inclusion in
Doctoral Dissertations 1896 - February 2014 by an authorized administrator of ScholarWorks@UMass Amherst. For more information, please contact
scholarworks@library.umass.edu.
Recommended Citation
Wu, Dong,, "Design, synthesis and assembly of genetically engineered proteins : simple routes to biocatalytic surfaces." (1997).
Doctoral Dissertations 1896 - February 2014. 972.
https://scholarworks.umass.edu/dissertations_1/972

DESIGN, SYNTHESIS AND ASSEMBLY OF GENETICALLY ENGINEERED
PROTEINS: SIMPLE ROUTES TO BIOCATALYTIC SURFACES
A Dissertation Presented
by
DONG WU
Submitted to the Graduate School of the
University of Massachusetts Amherst in partial fulfillment
of the requirements for the degree of
DOCTOR OF PHILOSOPHY
September 1997
Department of Polymer Science and Engineering
© Copyright by Dong Wu 1997
All Rights Reserved
DESIGN, SYNTHESIS AND ASSEMBLY OF GENETICALLY ENGINEERED
PROTEINS: SIMPLE ROUTES TO BIOCATALYTIC SURFACES
A Dissertation Presented
by
DONG WU
Approved asL to style and content by:
David A. Tirrell, Chair
Robert W. Lenz, Member
Thomas L. Mason, Member
Richard\(. Farris, Department Head
Department of Polymer Science and Engineering
DEDICATION
To my parents
ACKNOWLEDGMENTS
I would like to express my deepest gratitude to my thesis advisor, Professor David A.
Tirrell, for his support and guidance during my graduate school years. His dedication to
science and positive attitude influenced me a great deal. He has been a mentor for me, not
only from his direct teaching but also by setting an example of an excellent scientist and a
generous person. I will always consider myself lucky to be one of his students.
I would like to thank members of my committee. Professor Robert W. Lenz and
Professor Thomas L. Mason, for their enthusiasm and helpful suggestions for my
projects. I appreciate their effort in helping me to grow professionally over the years.
Dr. Greg Dabkowski and Professor Julian F. Tyson have been of great help to me in
the flow injection analysis experiments. It was very pleasant to collaborate with them and
beneficial for me in increasing my knowledge in analytical chemistry. I would Hke to
thank Andy Curtis of the Massachusetts Pesticide Laboratory of tiie University of
Massachusetts for cross checking my samples and providing useful information on
pesticides.
I would like to extend my appreciation to all of the members of Dr. Tirrell's
laboratory, with whom I had a lot of helpful discussions and who exposed me to a variety
of different fields. I will always cherish the friendship from Carissa Soto and Wendy
Petka, with whom I have shared good and bad times together throughout all my years in
graduate school; and from whom I have learned so much about life in general. My
graduate school would not have been so memorable without them. Special thanks go to
Laurie Gower, Susan Dawson, Dr. Wendy Naimark, Dr. Tim Deming, Dr. Vincent
Conticello, and Dr. Jan van Hest, with whom I really enjoyed working and who helped
me with various topics.
V
I would like to acknowledge my Chinese friends, Hairou Wang, Xiaodong Liu, Zhe
Zhang, Ning Li, Yuanqiao Rao and Xing Jing, who have been very caring and
encouraging.
I would like to thank my American family, the DePillis. Mario and Freda gave me a
home since I came to the US at 22. Over the years they have taken care of me as their
daughter and sometimes worried about me just as they worried of their own children.
Their generous love and belief in me have helped me to go through various stages of my
life professionally and personally in this foreign country. Their three sons, Vincent,
Mario Jr., and Alex, have become my dear American brothers. I would like to thank our
family friend. Dr. Edward Westhead, who was the first one introducing me to Dr.
Tirrell's research projects which interested me immediately.
Finally, I would like to thank my parents, who taught me values of life and initiated
my interest in science. And my brother. Dr. Bing Wu, who was always so protective of
me when I was growing up. I would not have made it to today without their love, help
and advice. I would also like to acknowledge my 20-day old nephew, John Benjamin
Wu, who has made me a happy and proud aunt. At last, I would like to thank my fiance.
Dr. Yong Hsu, for his love and support in my last stressful years in graduate school. I
am grateful for having such a close and supportive family.
vi
ABSTRACT
DESIGN, SYNTHESIS AND ASSEMBLY OF GENETICALLY ENGINEERED
PROTEINS: SIMPLE ROUTES TO BIOCATALYTIC SURFACES
SEPTEMBER 1997
DONG WU, B.A., JILIN UNIVERSITY, P.R. CHINA
M.A., UNIVERSITY OF MASSACHUSETTS AMHERST
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor David A. Tirrell
Natural proteins (e.g., enzymes and antibodies) perform versatile functions with high
activity and specificity. Their applications, however, are limited because of their poor
material properties. Novel biocatalytic materials are proposed to combine materials
properties with biological functions. Synthesis, assembly and application of a class of
such materials are presented in this dissertation.
Hybrid artificial proteins, with artificial polypeptides fused with natural proteins, are
produced as "sticky enzymes" where the artificial domain binds to surfaces while the
natural domain performs catalytic functions. The artificial domains are a family of
repetitive polypeptides with sequence motifs -[-(AlaGly)xZGly-]-n (Z = Glu or
ProGlu). The natural domain is a bacterial phosphotriesterase which catalyzes rapid
hydrolysis of organophosphorus pesticides. The target proteins are constructed via
recombinant DNA technology and expressed in Escherichia coli. All the hybrids, with
molecular weights varied from 55 to 65 kDa, exhibit catalytic activity for hydrolysis of
paraoxon. The hybrid containing [(AlaGly)3ProGluGly]i6 exhibits Michaelis-Menten
constants of Km = 120 ptM and kcat = 2500 s-i. The immobilized hybrid is adsorbed on
cationic microsphere resins, yielding 72% relative activity compared with the soluble
form. A column reactor containing the immobilized hybrid showed rapid hydrolysis of
paraoxon.
vii
In a related investigation, a recombinant phosphotriesterase with six consecutive
histidine residues at the N-terminus is produced in E.coli
. The recombinant enzyme,
purified by metal chelate affinity chromatography, catalyzes hydrolysis of paraoxon with
a kcat of 3880 S"^ and Km of 150 |iM. The enzyme is immobilized on non-porous silica
microspheres at 34 units/mg and exhibits kcat of 3490 s-^. The immobilized enzyme
shows higher stability compared to the soluble enzyme.
A flow injection analysis device using immobilized recombinant phosphotriesterase as
enzyme reactor has been constructed. Paraoxon in aqueous solutions was determined at
low detection limit (5 ng/ml), wide linear range (25 to 25(X) ng/ml), good precision
(R.S.D.= 0,7-5,8%) and sample frequency of 24 samples per hour. The proposed
method, by virtue of its simplicity, sensitivity and specificity, provides good potential as
an alternative analytical tool for rapid and easy detection of organophosphate pesticides.
viii
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CHAPTER 1
INTRODUCTION
1.1 Motivation
In the early 1980s, little more than a decade ago, the term "genetic engineering" was
hardly known outside the research laboratory. However, in the few short years since
they appeared, the first fruits of genetic engineering—products made by organisms
implanted with a foreign gene—have contributed handsomely to human welfare. Large
quantities of previously scarce therapeutic proteins are produced through genetic
engineering, among which are insulin, human growth hormone, and tissue-plasminogen
activator (or t-PA). In 1989 genetic engineering products were selected as one of the ten
outstanding engineering achievements by the National Academy of Engineering during
the past 25 years, along with the moon landing and computation technologyI By now, it
is commonly recognized that genetic engineering has the potential to revolutionize
medicine, agriculture, and the environmental industry, and to change our lives more than
perhaps any other scientific or technological advance.
From a polymer science point of view, genetic engineering provides excellent
opportunities to produce polymers with well-defined molecular architecture, something
that conventional polymer synthesis has not been able to accomplish. Conventional
polymerization—chemical synthesis methods—are statistical processes, resulting in
polymeric materials that are mixtures characterized by substantial molecular heterogeneity.
Although enormous efforts have been devoted to develop synthetic methods to give
controlled molecular architecture, there has not been a method to date where sequence,
molecular size, molecular weight distribution and stereochemistry of polymers can be
absolutely controlled at the same time. On the other hand, biological synthesis of proteins
1
involves template synthesis of messenger RNA from the DNA containing the gene
(transcription) followed by production of the protein from the mRNA template
(translation). Such biological synthesis machinery allows enormous amounts of proteins
to be synthesized precisely according to DNA information, to support our everyday
activities. Inspired by the accuracy and efficiency of nature, our research group has
applied the principles of protein expression to explore biological synthesis of polymeric
materials^. In addition to precise control of molecular architecture, biological synthesis
usually takes place at room temperature under normal pressure and produces
biodegradable waste, in contrast to chemical processes that often involve high temperature
and pressure. The biological synthesis of polymeric materials has been realized by
advances in recombinant DNA technologies, including the availability of the DNA
synthesizer to produce artificial genes readily. Through genetic engineering, polymers
with precisely controlled molecular architecture were synthesized, to form well-defined
crystalline lamellae-', novel liquid crystal phases'* and surface functionality.
Given the success of design and synthesis of polymeric materials with defined
structural properties and surface functions, we have explored the capacity of genetic
engineering to combine materials properties with biological functions derived from natural
proteins. Natural proteins have evolved over billions of years to perform particular
biological functions, most of them with bewilderingly high activity and specificity. Yet
natural proteins are pooriy defined materials for applications. Proteins in solution are
hard to use in continuous operational processes; many proteins are unstable and lose
activity in a short period of time; and recovery of proteins from the reaction product is
difficult, thus making the operation costly. Incorporation of materials properties into
natural proteins would allow scientists to harvest biological functions in the forms of
particles, surfaces, and membranes. The motivation of this thesis work is therefore, via
genetic engineering, to provide simple routes to produce biocatalytic materials and
assembly of biocatalytic surfaces. Chapter one introduces a general background and
2
current review of research fields involved in the thesis work. Chapter two describes one
approach to give materials properties to natural proteins, demonstrated by fusion of an
artificial polypeptide with an enzyme. Chapter three reports engineering of a natural
enzyme by immobilization on a solid support with retention of high enzymatic activity.
Chapter four exhibits an application of the immobilized enzyme in a biosensor device for
continuous detection of organophosphate pesticides.
1 .2 Protein Engineering
1.2.1 Design
Nature has evolved over billions of years to provide an enormous number of proteins,
which fold into a variety of structures and cairy out a diversity of functions. Studying
and manipulating natural proteins has lead scientists to understand their folding pathways,
thermodynamic stability, and catalytic properties. Such understanding is enhanced and
ultimately tested by the ability to design systems to achieve desired structures and
functions, with goal of eventually producing novel macromolecules that will be "made to
order" for solving important chemical and biochemical problems and having applications
ranging from industrial catalysis to biomedical engineering. Two very different
approaches have been pursued in novel protein design: (i) engineering natural proteins for
modification and improvement of their functions, (ii) designing functional proteins
entirely de novo. Here we will give a brief summary of recent advances with both
approaches, with emphasis on fields related to the thesis work.
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1.2.2 Engineering of Natural Proteins
Many natural proteins comprise structural scaffolds that are quite robust and tolerant
of a wide variety of sequence modifications^. Modem genetic engineering procedures
have made it possible to produce natural proteins in large quantities, and to modify their
primary structures, with concomitant control of physico-chemical and biological
characteristics^. As a result, it is possible to tinker with natural structures and thereby
engineer proteins with modified specificity and activity.
(I) Alteration of Properties of Natural Proteins
Natural proteins have been engineered to exhibit new functions (such as catalytic
activities). A very powerful and widely applicable approach is the design of catalytic
antibodies^. Lemer and coworkers explored the antibody's tolerance of enormous
variation of hypervariable loops with corresponding binding specificity^. By using
antigens (haptens) that resemble the transition state of a reaction, antibodies can be raised
to catalyze the reaction by specific binding and stabilizing the rate-determined transition
state on the reaction pathway. Hundreds of catalytic antibodies have been developed for
catalysis of a variety of chemical reactions, some for which no natural enzyme is known.
Antibodies have been produced to catalyze hydrolysis of phosphate triesters by use of an
amine oxide hapten to mimic the electrostatic features of the transition state^. A rate
enhancement of 10^ was observed for catalytic hydrolysis of a phosphate triester by the
antibody.
Enzymatic catalysts are of significant industrial interest because they are able to
perform complex chemistry efficiently and because they are biodegradable. Their
commercial use, however, has been limited because they are often too fragile under
conditions of commercial manufacturing processes. Recendy, a new technology was
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developed by scientists at Altus Biology (Cambridge, MA) of crystallizing and chemically
cross-linking (with glutaraldehyde, etc.) enzymes to produce stable heterologous catalysts
from crude protein mixtures. The cross-linked enzyme crystals (CLECs) retain catalytic
activity while gaining thermal stability, conformational stability and reduced proteolytic
degradation. It is reported that the resulting products can withstand extremes of pH,
temperature (above 50 °C), and use in organic solvents^. The stability of CLECs may be
a result of the crystalline nature of the material, combined with the covalent cross-linking
of the enzyme molecules. CLECs are being explored for applications in aqueous
solutions^ ^ and in organic solvents^ ^' In recent years there has been much interest in
the use of enzymes as catalysts in organic syntheses and polymerization'^. However, the
synthetic potential of enzymes has been limited by the low activity of enzymes in organic
solvents, in large part due to conformational changes that occur upon dehydration with
lyophilization^'*. CLECs, on the other hand, are solid crystalline particles that are
insoluble in aqueous and organic solvents and show superior catalytic activity as
compared to the "amorphous" enzymes in anhydrous organic medium'^. So far there are
5 CLEC catalysts that have been produced in multi-kilogram scale and commercialized by
Altus Biologies^. The company has recently received a contract from the Department of
Defense to produce cross-linked enzyme crystals of phosphotriesterase from
Pseudomonas diminuta for neutralization of nerve gas'^.
(II) Recombination of Properties of Natural Proteins
Besides modifications of natural proteins through changes of small amount of
residues as mentioned above, another approach to give novel function is by
rearrangement of natural proteins to combine properties from different proteins and,
ultimately, to execute multiple functions in a single polypeptide.
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Proteins that exhibit two biological functions on a single polypeptide chain exist in
nature, with different functions carried out by different domains. Such combinations not
only promote optimal performance of the protein but also allow efficient production of a
variety of polypeptide chains from limited genetic constructs. Antibodies, as the first line
of defense against bacterial and viral infection, have been shown to carry Fv and Fab
fragments as antigen-binding domains and Fc fragments as effector domains triggering
elimination of the antigen^*^. One of the important mechanisms accounting for the
enormous diversity of antibodies arises from recombinatorial arrangements of the domain
elements of the antibody genes. A second example is provided by myosin, which is
essential in muscle contraction and cell division in eukaryotic cells. Myosin consists of a
globular head fragment (SI) at the N-terminus that binds to actin, and a fibrous light
chain fragment that serves to interact between the actin filaments^ ^. Chicken myosin
containing two different light chains is derived from a single gene by two different
transcriptions and RNA processings^.
With the advance of molecular biology, fusion proteins can be readily produced by
ligation of genes encoding different proteins or domains. The resulting fusion proteins,
in many cases, exhibit the individual biological activities of each protein domain. Fusion
proteins have been used to facilitate recombinant protein expression in heterologous
hosts. Reporter enzymes
—
proteins with good expression levels and easy assays—have
been fused with target proteins for increased stability^^, ease of detection^^ and protein
secretion^^. Fusion genes encoding domains that recognize specific ligands are widely
used in affinity chromatography to assist purification of recombinant proteins^^*
Monoclonal antibodies have been genetically engineered and endowed with new
properties'^. Therapeutic antibodies are made by fusing gene segments encoding
antigen-binding domains (Fv or Fab fragments) to genes encoding toxins^^ and
enzymes^^. The engineered antibodies can target toxins or enzymes to specific types of
cells. Another example is immunoadhesins in which a ligand specific for a cell-surface
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receptor is attached to an Fc fragment. The protein binds to the surface of cells infected
with HIV and kills the cells by antibody-dependent cell-mediated cytolysis^"^.
Genes encoding subunits from a complex enzyme have been fused together to
produce fusion proteins to elucidate the structure-property relationships of enzyme
complexes^^. Genes encoding enzymes that are involved in sequential reactions have
also been joined. The product of the reaction catalyzed by the first enzyme serves as the
substrate of the second enzyme domain. The fusion protein was used as a conceptual
"chain reaction channel" to achieve higher reaction efficiency^^.
Genetically engineered affinity domains were fused to proteins of interest to facilitate
enzyme immobilization^"^- Such fusion proteins could be immobilized by taking
advantage of the specific binding of the affinity peptide to an affinity adsorbent, while the
partner domain exhibits biological activity on the surfaces^^' Of those fusion proteins
the purification and immobilization can be done in a single step through the specific
recognition processes drawn from nature, e.g., antibody-antigen, enzyme-substrate or
receptor-ligand interactions. This fusion protein approach allows immobilization of
enzyme without denaturation and with retention of high catalytic activity.
The first report of a genetically engineered fusion protein for enzyme immobilization
was constructed by fusion between the gene (abg) for a P-glucosidase (Abg) of an
Agrobacterium sp. and part of the gene (cex) for an exoglucanase (Cex) of Cellulomonas
fimi The fusion protein (Abg-CBDcex) exhibited the cellulose-binding properties of
Cex and (3-glucosidase activity of Abg. The fusion protein retained 42% of its p-
glucosidase activity when bound to cellulose. The binding was stable enough to allow
continuous hydrolysis of substrate by the enzyme without detectable leaching of the
enzyme from the cellulose. Recently, the same research group reported fusion of
CBD/RGD as a linking molecule between a cell and a cellulose surface^^. The sequence
Arg-Gly-Asp (RGD) in extracellular matrix proteins such as fibronectin, collagen, and
laminin mediates cell attachment by interacting with proteins of the integrin family of cell
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surface receptors. The fusion protein containing the RGD peptide fused to the C-
terminus of CBD domain promoted the attachment of mammaUan cells, such as green
monkey Vero cells, to polystyrene and cellulose acetate.
Protein A from Staphylococcus aureus (SpA) is a receptor for the Fc domain of
several classes of antibodies including immunoglobin (IgG) and has been used for protein
immobilization. A hybrid protein consisting of protein A and the enzyme p-lactamase
was adsorbed on IgG-coated Sepharose matrices^"* with higher specific activity and lower
Km relative to covalentiy immobilized P-lactamase. Adsorption of the hybrid protein on
the support resulted in increased stability to thermal deactivation. A similar approach was
reported by Kondo and coworkers who used "affinity tag AG" consisting of IgG-binding
domains of protein A and those of protein G from Streptococcus strain G 148 to faciUtate
immobilization of P-galactosidase-'^. AG^gal retained approximately 75% of its activity
upon immobilization and the binding was stable enough to allow repeated use.
Hentz and coworkers described an affinity chromatography system using a fusion
protein which contained calmodulin (CaM) and protein A (ProtA)^^, exploring the
molecular recognition properties of the two components of the fusion. In particular, CaM
serves as the anchoring component by virtue of its binding properties toward
phenothiazine. Thus, the ProtA-CaM can be immobilized on a solid support containing
phenothiazine from the C-terminal domain of the fusion protein, while Protein A at the N-
terminus serves as the affinity site for DnaK (a heat shock protein). DnaK is released
upon addition of ATP under mild conditions. The affinity column can be regenerated by
removal of the immobilized fusion with addition of EGTA and reloading of fresh ProtA-
CaM.
An oligopeptide containing multiple histidines was used for protein immobilization on
chelating columns charged with Zn ion^^. The polypeptide with repeating sequence Ala-
His-Gly-His-Arg-Pro was fused to the N-terminus of p-galactosidase and to the C-
terminus of a synthetic IgG-binding protein. Relatively strong interaction could be
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observed for the fusion based on four or eight repeating units of the affinity peptide. The
fusion proteins were found to be eluted from the resin at different pH depending on the
number of repeats. More recently, Hochuli and coworkers used N-terminal hexahistidine
fusion proteins to immobilize p-galactosidase to a Ni2+-nitrilotriacctic acid adsorbent^^.
The fusion protein retained 64% of its p-galactosidase activity when bound to the
adsorbent. Allyl-p-D-galactopyranoside was synthesized from lactose and allyl alcohol
on a gram scale by the immobilized p-galactosidase.
Fusion proteins containing polyionic peptides were reported as tool to produce
immobilized enzyme catalysts^l Enzyme immobilization was realized through a fusion
protein of yeast a-glucosidase containing at its C-terminus a polycationic hexaarginine
fusion peptide. This fusion protein can be directly adsorbed from crude cell extracts on
polyanionic matrices. Upon immobilization, the stability of the fusion protein is not
affected by pH, urea, or thermal denaturation. The enzymatic properties are not
influenced by this noncovalent coupling. The immobilized enzyme was used in a column
reactor for production of carbohydrates with good operational stability.
1.2.3 Engineering of Artificial Proteins
Perhaps the more adventurous step in protein engineering is to create completely new
protein with novel functions. Designing new proteins from scratch—based on the
accumulated knowledge of protein structures and functions—takes an active approach in
understanding nature, and very possibly would open a wide range of new applications.
Many de novo proteins have been produced that fold into predetermined structures'^*
such as helical bundles'*^^*'*'. Moreover, the goal of protein design is to produce novel
macromolecules that possess interesting and useful functions. Most attempts at the
design of function have focused on binding and/or catalysis. Proteins have been
produced that contain metal binding sites, mostly Zn(II) and Cu(II), either by reproducing
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the geometry and associated structural and catalytic properties of natural sites or by
completely new design'*^ y^^^ ^^^^^^ four-helix bundles were modified to incorporate
metal binding sites in which Zn (II) was bound with K<i of 2.5 x 10 "8 M"*^. Ghadiri and
Case constructed a three-helix bundle that has a binding site for Ru(II) at one end and a
site for Cu(II) at the other^. The synthetic protein was shown to bind both metal ions
with each metal binding specifically to its designed site, directing the self-assembly of the
three peptides and two metal ions into a unique heterodinuclear metalloprotein.
Polypeptides of extremely hydrophobic sequence were designed to bind the insecticide
DDT*^, with dissociation constant of 9 x 10 M.
Design of catalytically active proteins has remained a challenging topic. The
Chymohelizyme used by Hahn and coworker was designed as an esterase with a
specificity similar to chymotrypsin"*^. The Helichrome employed by Sasaki and Kaiser
was designed as an aniline hydroxylase"*^ . The helichrome exhibited activity similar to
those of natural proteins such as hemoglobin for hydroxylating aniline. Both designed
catalytic sites were based on sites found in natural proteins and crosslinked to preorganize
the structure and position of the binding pockets. On the other hand, Benner and
coworkers designed a novel enzyme that catalyzes the decarboxylation of oxaloacetate
with the active site designed from scratch. The kcat of the synthetic peptide was 5 orders
of magnitude lower than that of the natural enzyme but still around 900 fold larger than
the rate constant of the uncatalysed reaction"*^.
Novel peptides have been designed to self-assemble into new materials. Ghadiri and
coworker designed a peptide of sequence cyclo[-(D-Ala-Glu-D-Ala-Gln)2], which adopts
a flat ring conformation. At low pH, the intermolecular hydrogen bonding between the
flat rings forces spontaneous self-assembly of the peptide into long hollow tubes
nanometers long and the internal diameters are dictated by the size of the cyclic
peptide^^'^o.
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1.2.4 Protein-Based Polymeric Materials
Many naturally occurring structural proteins such as silk, elastin and collagen show
properties that fascinate materials scientists. For example, dragline silk exhibits both
tensile strength and extent of elongation superior to that of other high-performance
synthetic fibers^^ The sequences of many structural proteins contain long stretches of
highly repetitive amino acids. A variety of polymeric proteins are produced based on
sequences of naturally occurring structural proteins^l Among those are polypeptides
developed by Urry and coworkers that expand and contract in response to pH^^- 53
-phe
polymers contain the repeating sequence (Val-Pro-Gly-X-Gly), where X is Val or Glu at
a ratio of 4: 1. At neutral pH the glutamic acid residues are charged, causing expansion of
the polymer. When the pH is lowered to 3, the Glu side chains are converted to neutral
COOH, resulting in collapse and contraction of the polymer. Through such mechano-
chemical coupling, the polymer was able to pick up weights 1000 times greater than that
of the polymer itself.
Over the last ten years or so, our research group has produced de novo protein-based
polymers to achieve well-defined molecular architecture. Uniform polymer chains are
produced to answer important fundamental questions (e.g., lamellar crystal formation,
alignment of liquid crystals) and assembly into new polymeric materials^^. The design of
the sequences of such polymers is based on concepts and observations from both
polymer chemistry and structural biology. The first artificial polypeptides contained
repeating sequences of [(AlaGly)3ProGluGly]^'^. The protein-based polymer was
expected to form lamellar crystal structures, with the AlaGly triads forming extended P-
sheet and ProGlu residues initiating the chain folding. Artificial genes encoding the
monomeric units were synthesized by solid state chemical synthesis and enzymatically
polymerized into DNA multimers, which served as templates to produce the
corresponding artificial proteins. The resulting proteins didn't form crystal structures as
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expected, rather they were shown to be mostly amorphous structures. On the other hand,
a series of polypeptides designed later, with deletion of the proline in the sequence,
folded into lamellar crystals whose thickness is controlled by the periodicity of the
primary sequence^. Recent evidence has shown that the glutamic residues, being bulky
and difficult to fit into the crystal lattice, were indeed present on the surface of the
structures as designed. Currently, efforts have been made where the sequences are
systematically varied to further understand the factors that determine molecular structure
and supramolecular assembly of polymers in the solid state. Furthermore, the scope and
applications of the genetically engineered polymers are expanded by our success in
incorporating unnatural amino acids into the polypeptides and thereby introducing new
functionality that is not available with the twenty natural amino acids.
1.3 Phosphotriesterase
Organophosphate (OP) pesticides have become the largest class of pesticides in
industrial countries in the last fifty years, due to their high effectiveness^^. However, the
pesticide loses persistence in soil after a period of application. Investigations led to the
isolation ofpseudomonas diminuta strain MG that contained the plasmid-born enzyme
phosphotriesterase(called parathion hydrolase by the authors)^^. The gene encoding the
enzyme was first identified and sequenced by Serdar and coworkers in 1989^^.
Subsequently Mulbry and coworkers characterized and sequenced the gene for bacterial
phosphotriesterase from Flavobacteriwn. and showed that the DNA sequences are
identical in both cases^^ . The enzyme is translated as a larger precursor protein of 365
amino acids prior to cleavage of a 29-amino acid leader peptide from the N-terminus to
form the nature enzyme. The gene encoding the bacterial phosphotriesterase has been
subcloned into a variety of expression vectors^^ and the protein purified to homogeneity
using insect cells, Streptomyces Uvidans, and Escherichia coli as hosts^^-
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Significant improvements in the levels of protein expression in E. coli have been obtained
by deletion of the 33 N-terminal amino acids and replacement of the first 5 lac Z residues
(Met-Ile-Thr-Asn-Ser-) followed by the enzyme residues (-Gly-Asp-Arg-)^*.
The natural substrates of the phospholriesterase are still unknown. The enzyme is a
highly efficient catalyst for the hydrolysis of an extensive variety of synthetic
acetylcholinesterase inhibitors, most of which are organophosphorus pesticides and nerve
agents<^2 (pigure 1.1). It catalyzes the hydrolysis of paraoxon (O.O-diethyl-O-/?-
nitrophenyl phosphate)with rate enhancements that approach 1()12. The structure and
mechanism of phosphotriesterase have been extensively investigated using kinetic''^,
genetic^\ and spectroscopic methods^"^'^, chemical modification and inactivation^''^'^
and X-ray diffraction^^'"^^.
The X-ray analysis of the crystal structure of the apoen/.yme revealed that the
phosphotriesterase consists of a honKxiitner cf 39 kDa subunits, with an o/p-barrel fold
with eight strands of parallel p-pleated sheet"^". Subsequent studies of the holoenzyme
revealed that the active site contains two equivalents of cadmium ions separated by 3.7 A;
the site is located at the C-temiinal portion of the (3-barrel. The three-dimensional
structure of the Zn2+/Zn2+-substituted enzyme has subsequently been reported (Figure
1.2)^-^. The zinc ions are separated by 3.3 A and bridge with ligands of a carbamylated
lysine residue (Lys 169) and a hydroxide. The structure of the co-crystallized complex
with diethyl 4-methylbenzylphosphonate shows that the substrate analog occupies a site
near the binuclear metal center, with the phosphoryl oxygen situated 3.3 A from the more
solvent-exposed zinc ion. The aromatic portion of the inhibitor binds in a fairly
hydrophobic pot'ket. A striking feature of the active site pocket is the lack of direct
electrostatic interactions between the inhibitor and the protein, which might explain the
broad substrate specificity exhibited by phosphotriesterase.
The catalytic reaction mechanism of the i)hospholriesterase has been shown to
proceed via an SN2-like associative mechanism with activation of a water molecule by the
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metal center, followed by the direct hydrolysis of the substrate resulting in an inversion of
configuration at the phosphorus center and dissociation of products^- ^4 Bronsted plots
have indicated that the rate-determining step changes from hydrolysis of the P-O bond to
a conformational change and/or binding events as the pKa value of the leaving group is
altered^^. 75 study of structure-reactivity relationships and the solvent viscosity effect
demonstrated a product-like transition state structure; the rate of hydrolysis with paraoxon
as a substrate is limited by diffusion of the enzyme and substrate rather than the actual
bond cleavage step^^.
The precise roles for each of the two metal ions in catalytic reaction remain unknown.
Recent NMR, EPR, and X-ray crystallography studies have shown that the water
molecule that attacks the phosphoryl center is bound directly to the binuclear metal
center^^' The two native Zn2+ ions can be substituted with either Co2+, Ni2+,
Cd2+, or Mn2+ with the restoration of full catalytic activity''^. An enhancement of the
specific activity has been reported in whole cells when divalent metal ions were
supplemented in the growth medium^^-
Six out of the seven histidines in the enzyme have been shown to be essential in
substrate binding and catalysis, through studies of site specific mutagenesis of the seven
histidine residues to asparagine^^. Inactivation studies of the phosphotriesterase with
diethyl pyrocarbonate and the pH rate profiles for the hydrolysis of paraoxon by the
phosphotriesterase suggest that an active site histidine residue acts as the general base or
proton shuttle group^^. X-ray crystallography shows the coupled binuclear metal center
is embedded within a cluster of histidine residues^^' The more buried zinc ion is
surrounded by His 55, His 57, Lys 169, Asp 301, and the bridging hydroxide in a
trigonal bipyramidal arrangement. The more solvent-exposed zinc ion is tetrahedrally
ligated to Lys 169, His 201, His 230, and the bridging hydroxide. These studies lead to
a working model of the active site, as shown in Figure 1.3, where the metals serve to
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polarize the phosphoryl oxygen bond and facilitate the nucleophilic attack of the metal-
bound hydroxide to give the hydrolysis products.
Parathion is an organophosphate pesticide that is extremely toxic to higher
organisms''^. The utilization of phosphotriesterase for the enzymatic removal of
parathion from pesticide containers or to clean soil spills has been demonstrated by
Munnecke and coworkers''^-^^ They have studied the degradation of parathion by a
mixed microbial culture and found the major metabolites to be p-nitrophenol (PNP) and
diethylthiophosphoric acid^^. Hydrolysis of parathion reduces its toxicity by nearly 120-
fold and releases water-soluble metabolites that are more available to further microbial
degradation.
Immobilized forms of the phosphotriesterase for degradation of pesticides have been
described in two studies so far. Bacterial cell lysates containing phosphotriesterase were
covalently bound to controlled porous glass ^CPG) and silica (CPS)^^- The author
reported relative activities of 3-41% of the immobilized enzyme depending on the amount
of protein loaded. The maximal relative activity was achieved with only 7 units of
enzyme bound per grams of porous silica. Caldwell and coworkers immobilized purified
phosphotriesterase on trityl agarose through physical adsorption^"*. The resulting
preparation was found to have 40% maximal performance of free soluble enzyme in
degrading paraoxon; however, paraoxon and other substrates all showed affinity toward
the trityl agarose matrix. Addition of 10% methanol was required to suppress adsorption
of paraoxon.
1.4 Immobilized Enzymes
The term "immobilized enzymes" was first adopted in 1971 at the first Enzyme
Engineering Conference held at Henniker, New Hampshire, according to the suggestion
of E. Katchalski-Katzir^. The definition of immobilized enzymes—enzymes that are
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physically confined and localized, with retention of their activity, and which can be used
repeatedly and continuously^S—also gives a summary of the advantages of the system.
Compared with their soluble counterparts, immobilized enzymes have considerable
operational advantages, including compatibility with continuous operations, ease of
product recovery and purification, and readiness for repeated use. In many cases, it is
found that enzymes gain stability with respect to denaturation upon heating and prolonged
storage in the immobilized form^^* Immobilized enzymes have served as model
systems for natural, in vivo, membrane-bound enzymes^l Recentiy, immobilization was
exploited to modify enzyme activity^^.
1.4.1 Immobilization Techniques
Enzymes can be immobilized by a number of techniques, which can be broadly
classified as follows^^:
(1) Chemical methods
(i) Covalent bonding of the enzyme to a derivatized, water-insoluble matrix. The
most widely used coupling agents including glutaraldehyde and carbodiimides. The
advantage is formation of a stable enzyme-support complex; disadvantages include
complication of chemical reactions, especially the possibility of reaction with essential
residues for activity and thereby loss of enzymatic activity. For each specific enzyme,
developing a chemical coupling reaction to immobilize the enzyme without loss of
enzymatic activity can be time consuming and difficult for sensitive enzymes.
(ii) Crosslinking, most commonly by glutaraldehyde, bi-isocyanate, or bis-
diazobenzidine. The procedure is relatively simple, and strong intra- and inter-molecular
bonding results in stable proteins. However, the process requires a large amount of
enzyme and the reaction is difficult to control.
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(2) Physical Methods
(i) Adsorption (through hydrogen bonding, ionic interactions, or hydrophobic
forces). This method has the advantage of being simple and mild, causing less disruption
of the enzyme. However, the linkage is highly dependent on pH, solvent and
temperature. There are possibilities of leakage over extended time of use.
(ii) Entrapment in gels or membranes. This method is universal to all proteins, and
requires relatively mild conditions. At the same time there are large diffusion barriers and
the possibility of enzyme leakage.
1.4.2 Applications of Immobilized Enzymes
1.4.2.1 Biocatalysts and Bioreactors
Enzymatically catalyzed reactions take place at room temperature, in aqueous
solutions, and at normal pressure. Enzymes have been used for centuries in the food
industry, and more recentiy, have found applications in the pharmaceutical and chemical
industries^. Immobilized enzymes are quite stable, often more stable than their soluble
counterparts. These features enable bioengineers to construct enzyme reactors that
facilitate a particular catalytic reaction. Immobilized-enzyme reactors enjoy advantages
such as high enzyme loads, prolonged enzyme activity, the ability to recycle products,
high flow rate, reductions in costs, energy and waste products, easy scale up to large
systems, and high yields of pure materials^^. Currentiy the reactors in use include batch-
fed stirred-tank, continuous stirred-tank, continuous packed-bed and fluid-bed reactors^.
Immobilized enzyme reactors have been used in the food, pharmaceutical and
chemical industries. The first industrial use of an immobilized enzyme reactor was
reported in 1967 by Chibata and coworkers at Tanake Seiyaku Company in Japan^l
They developed a column of immobilized aminoacylase on DEAE-Sephadex to resolve
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synthetic racemic DL-amino acids into optically active L-amino acids. Since then there
have been extensive research and a steady increase in the number of industrial processes
based on immobilized enzyme reactors^. Among these processes is immobilized glucose
isomerase, which catalyzes transformation of glucose to fructose. The estimated world
wide production of high-fructose com syrup was 8 x 10^ tons in 1992^^ qj^^^
examples include immobilized lactase in the hydrolysis of lactose in milk^^. production of
penicillin compound by immobilized penicillin amidase^^; and synthesis of acrylamide
from acrylonitrile from immobilized nitrile hydratase^^.
1.4.2.2 Analytical Applications
Enzymes, with their unique specificity for specific substrates, make excellent
candidates for development of analytic systems specific for target analytes. The
attractions of immobilized enzymes from an analytical standpoint are primarily their
reusability, cost reduction, and the greater efficiency and control of their catalytic activity
(e.g., potentially longer half-lives, predictable decay rates and more efficient multi-step
reactions) Immobilized enzymes have been used in three forms for analytical
applications.
(1) Solid phase enzyme reactors, for use in continuous flow techniques such as flow
injection analysis and post-column derivatization in liquid chromatography^^.
(2) Membranes, incorporated into sensors such as potentiometic enzyme electrodes and
optical sensors^^.
(3) Films, for use in disposable, dry reagent knits with photometric detection^^.
Biosensors comprise biological sensing elements (e.g., enzymes, antibodies,
receptors) in close proximity or integrated with a signal transducer that is capable of
providing information on the composition of the surroundings. The emitted signal
(electrochemical, optical or thermal) is transmitted to a suitable calibrated recorder. In
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recent years, there have been important developments in the design and construction of
biosensors, such as amperometic and potentiometic enzyme electrodes, enzyme
thermistor devices, field-effect transistor-based biosensors, and fiber-optic sensors based
on bioluminescence and chemiluminescence. All of them employ immobilized enzyme of
various types^^. Biosensors have great potential as useful tools in diagnostics,
environmental monitoring, and in the food industry^^. Reagentless biosensors can be
constructed by co-immobilizing both enzymes and mediators onto a miniaturized electrode
using electropolymerization, thus improving the sensitivity and speed of the response^^*
Recently there are significant efforts devoted to electrochemical sensors, in which
direct electrical communication is made from an redox enzyme to an electrode surface
through conducting polymers. Certain monomers such as pyrrole, N-methylpyrrole,
aniline and tyramine were polymerized at a sufficiently positively charged electrode
surface; such conditions also bring most proteins to the surface^^^* Electronic
devices of this type could potentially be used as novel "biochips" in appropriate
networks.
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Figure 1.1 Catalytic hydrolysis of paraoxon by the phosphotriesterase
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Figure 1.3 Schematic representation of the postulated catalytic mechanism of
phosphotriesterase^^
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CHAPTER 2
HYBRID ARTIFICIAL PROTEINS: A NOVEL APPROACH TO COMBINING
MATERIALS PROPERTIES AND BIOLOGICAL FUNCTION
2.1 Introduction
Natural proteins (e.g., enzymes and antibodies) perform versatile biological
functions with high activity and specificity under mild reaction conditions; they are
biodegradable and environmental friendly. Proteins (mostly enzymes) have been used for
centuries in the food industry, and more recently, in the pharmaceutical and chemical
industries as well^ Modern genetic engineering procedures have made it possible to
produce natural proteins in large quantities, and to modify their primary structures, with
concomitant control of physico-chemical and biological characteristics^. Although there
is great demand for protein products, there are limitations as well: proteins in solutions
are hard to use in continuous operations; many proteins are unstable and lose activity
within short periods of time; and recovery of proteins from the reaction product can be
difficult (in fact, most bulk enzymes are discarded after a single use).
Effort to overcome these problems includes immobilization of natural proteins.
Immobilized enzymes—enzymes that are physically confined and localized, with retention
of their activity, and which can be used repeatedly and continuously-^—have considerable
operational advantages compared with free soluble enzymes. Immobilized enzymes are
compatible with continuous operations, easy to recover from product, and ready for
repeated use. In many cases, it is found that enzymes gain stability with respect to
denaturation upon heating and prolonged storage in the immobilized form"^' ^.
Immobilized enzymes have served as model systems for natural, in vivo, membrane-
bound enzymes^. Recently, immobilization was exploited to modify enzyme activity .
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Enzymes can be immobilized by a number of techniques^, including covalent bonding,
crosslinking, physical adsorption and entrapment in gels or membranes. Immobilized
enzymes have been used as heterogeneous biocatalysts in industrial processes^ including
racemic separation^, production of high-fructose com syrup and hydrolysis of lactose
in milk^^. More recently, immobilized enzymes have been applied in biosensors that are
finding increasing use in medicine, food quality control and environment monitoring^ ^
For each specific enzyme, developing an immobilization technique without loss of
enzymatic activity can be time consuming (and difficult for sensitive enzymes).
Genetically engineered affinity domains have been fused to proteins to facilitate
enzyme immobilization ^2"*'*. Such fusion proteins could be immobilized by taking
advantage of the specific binding of the affinity peptide to an affinity adsorbent, while the
partner domain exhibits biological activity on the surface^-^' Such fusions allow
immobilization of enzyme without denaturation and with retention of high catalytic
activity.
With advances in recombinant DNA technology, fusion proteins have been made
readily through manipulation of the genes of different proteins, by "cutting and pasting"
of restriction fragments, and subsequently producing target proteins in living organisms
(mostly in Escherichia coli). The resulting fusion proteins, in many cases, exhibit the
individual biological activities of each protein domain. Fusion proteins thus provide
opportunities for rearrangement of natural proteins to combine properties from different
proteins, and ultimately, to execute multiple functions in a single polypeptide.
A fusion protein has been constructed for enzyme immobilization by fusing a gene for
a P-glucosidase (Abg) and part of the gene for an exoglucanase (CBDcex)^^- The fusion
protein (Abg-CBDcex) exhibited the cellulose-binding properties of Cex and p-
glucosidase activity of Abg and retained 42% of its the p-glucosidase activity when
bound to cellulose. The sequence Arg-Gly-Asp (ROD) in extracellular matrix proteins
such as fibronectin, collagen, and laminin mediates cell attachment by interacting
with
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proteins of the integrin family of cell surface receptors. The same research group recently
reported fusion of CBD/RGD as a linking molecule between a cell and a cellulose
surface^
^ Protein A was fused with p-lactamase and adsorbed on IgG-coated Sepharose
matrices with higher specific activities and lower Km values relative to covalendy
immobilized p-lactamase^''
.
Adsorption of the hybrid protein on the support resulted in
increased stability to thermal deactivation. An affinity chromatography system using a
fusion protein which contained calmodulin (CaM) and protein A (ProtA)^^, was
immobilized on a solid support containing phenothiazine through CaM, while Protein A at
the N-terminus serves as the affinity site for a heat shock protein. The target protein is
released upon addition of ATP and the affinity column can be easily regenerated by
elution of the immobilized fusion with addition of EGTA and reloading of fresh ProtA-
CaM.
The above fusion proteins were immobilized by interactions of the affinity domain
with surfaces through the specific recognition processes drawn from nature, e.g.,
antibody-antigen, enzyme- substrate or receptor- ligand interactions. Oligopeptides
containing multiple amino acid residues have also been used for protein immobilization
through functional groups on the side chain of the residues. HochuH and coworkers used
N-terminal hexahistidine fusion proteins to immobilize P-galactosidase to the Ni2+-
nitrilotriacetic acid adsorbent^^. The fusion protein retained 64% of its p-galactosidase
activity when bound to the adsorbent. Allyl-p-D-galactopyranoside was synthesized
from lactose and allyl alcohol on a gram scale by the immobilized (3-galactosidase.
Another example is provided by a fusion protein that contains a polycationic hexa-
arginine and an N-terminal yeast a-glucosidase^^. This fusion protein can be directly
adsorbed from crude cell extracts on polyanionic matrices. Upon immobilization, tiie
stability of tiie fusion protein is not affected by pH, urea, or thermal denaturation. The
immobilized enzyme was used in column reactors for production of carbohydrates with
good operational stability.
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During the last decade, our research group has explored biological synthesis of
polymeric materials, to achieve well-defined molecular architecture including precisely
controlled sequence, predetermined chain length, monodispersity, and suitable
stereochemistry^^. By applying the principles of materials science and structural biology,
we have synthesized protein-based polymers with lamellar crystal structures, novel liquid
crystal behavior and defined functional groups on surfaces'^^*^'^. Given these successes
in the design and synthesis of polymeric materials with defined structural properties and
surface functions, it should be possible to produce hybrid artificial proteins as novel
biocatalytic materials to improve practical applications of natural proteins. Hybrid
artificial proteins, in which artificial repetitive polypeptides are fused with natural proteins
or subunits, are proposed as a new approach to combining materials properties with the
biological functions of natural proteins.
The hybrid artificial proteins we report here have the structures illustrated in figure
2. 1 . The natural domain is a natural protein (enzyme or antibody) a the certain biological
function; it is fused to an artificial domain that exhibits desired material properties.
Through the de novo design of artificial domains to confer useful and versatile materials
properties, the hybrid artificial proteins could lead to novel structures and functions and
allow material scientists to harvest biological activities in the forms of particles, films and
membranes. A few examples include:
(1) self-assembling protein arrays. When repetitive polypeptides self-assemble into well-
defined secondary structures (e.g., p-sheets or a-helices), the natural domain aggregates
in a regular pattern on the surface of the artificial peptide matrix.
(2) bioreactive surfaces. When the artificial polypeptide is designed to carry multiple
functional groups that promote interaction (e.g., physical adsorption and chemical
bonding) with surfaces; the natural domain partner retains biological function (e.g.,
enzyme for biocatalytic activities, or cell recognition domains to promote cell adhesion
and proliferation, etc.).
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(3) enzyme networks. With the artificial domains forming cross-linked structures and the
other enzymatic domain embedded in the network, the hybrid protein could produce an
"enzyme gel". The crosslinking density and the mechanical strength of the gel could be
varied with polypeptide functional groups and chain sequence. For example, by
designing the polypeptide sequence, polymeric gels will undergo conformational changes
with pH or temperature. Enzymatic reactions within the gel could be controlled by
diffusion of the substrate from solution into the gel.
(4) selective membranes. When the artificial domain self-assembles into membrane
structures, the natural partner acts as transport proteins that selectively transport
molecules (ions, small proteins, etc.) across the artificial membranes.
As a model system, we designed hybrid artificial proteins where the artificial domain
serves to bind to surfaces while the natural domain performs a catalytic function.
Versatile protein-surface interaction could be realized by variation of chemical properties
of the artificial domains. In order to achieve the desired properties, the artificial domain
must fulfill the following requirements: (i) useful chemical properties; e.g., functional
groups at precise positions to promote adhesion of the proteins to surfaces and
mechanical and physical stability. The natural protein domain, on the other hand, should
have the following character: (i) useful biocatalytic functions; (ii) tolerance towards
modification (fusion of artificial domain); (iii) ease of assay for activity.
A family of artificial domains was used in this work to gain control over chain length,
chemical and structural properties:
[-(AlaGly)xProGluGly-l-n 1 a: x=3 n=16
b: x=4 n=16
.[-(AlaGly)xGluGly-]-n 2 a: x=3 n=36
b: x=4 n=18
c: x=4 n=28
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d: x=5 n=14
e: x=6 n=14
Such polypeptides can be produced in E. coli in good yield and have been shown to
adopt random coil or p- sheet structures^! - 22. The periodic acidic side chains from the
glutamic acid residues were expected to provide affinity to basic surfaces. The natural
domain is a bacterial phosphotriesterase which catalyzes rapid hydrolysis of
organophosphorus pesticides and nerve agents^^. The phosphotriesterase we used here
contains the modified amino acid sequence reported by Mulbry and coworkers, which is
characterized by deletion of the 33 N-terminal amino acids of the native enzyme (from
native sequence ofpseudomonas diminuta ) and replacement by the first 5 lac Z residues
(Met-Ile-Thr-Asn-Ser-) followed by the enzyme residues (-Gly-Asp-Arg-), in order to
achieve significant improvements in the enzymatic activity in E. coli 2"*. The activity of
the enzyme can be easily determined, as the pesticide paraoxon can be enzymatically
degraded to release a brightly colored phenolic product with a maximal absorption at 400
nm. The enzyme has shown very good stability and has demonstrated unusually high
enzymatic activity2^, exhibiting a rate near the diffusion limit with substrate paraoxon2^.
The hybrid artificial proteins containing the repetitive polypeptides and
phosphotriesterase were expected to adsorb to basic surfaces through the acidic artificial
domain while the partner enzyme catalyzes hydrolysis of organophosphates. Such hybrid
artificial protein designs provide a generic and simple route to immobilization of proteins
without denaturation or loss of enzymatic activity. Given the broad substrate range of the
phosphotriesterase, the immobilized hybrid proteins are potentially useful for detection
and detoxification of organophosphate pesticides and chemical warfare agents.
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2.2 Experimental Section
2.2.1 Materials and Methods
The vectors pET-3b and pET-14b were purchased from Novagen. Restriction
enzymes BamH I, EcoR I, Pst I and Nde I as well as T4 ligase and DNA polymerase
were obtained from New England Biolabs. Ampicillin, Chloramphenicol, paraoxon
(diethyl-/7-nitrophenyl phosphate), (3-cyclohexylamino)-l-propanesulfonic acid (CAPS),
2-(N-cyclohexylamino)ethanesulfonic acid (CHES), (N-2-hydroxylethylpiperazine)-N-2-
ethanesulfonic acid (HEPES), (2-N-morpholino)-ethanesulfonic acid (MES) were
purchased from Sigma Chemical Company. All reagents except paraoxon were used as
received. Paraoxon was purified by dissolution in dichloromethane following by
extraction with 10 mM CHES buffer, pH 9.0 according to a reported procedure^. The
purified paraoxon was dissolved in water in a final concentration of 0.5 mM and stored at
4 "C. All the DNA manipulations were performed according to standard procedures'^.
Isopropyl-p-thiogalactoside (IPTG) was obtained from Calbiochem. Ni-NTA resin was
purchased from Qiagen, Inc. Econo-Pac lODG was obtained from Bio-Rad, Inc. DEAE
Sephadex A-50 and A-25, and QAE Sephadex A-50 were purchased from Pharmacia Inc.
Centriprep 10 ultrafiltration units were from Amicon Division, W. R. Grace & Co.
Protein-Pak DEAE was obtained from Waters Inc.
2.2.2 Recombinant DNA Construction
Construction of the recombinant DNA encoding the hybrid artificial proteins is
schematically shown in Figure 2.2. Plasmid pJK33 (obtained from Professor Frank
Raushel of Texas A&M University) was digested with restriction enzymes BamH I and
EcoR I. The resulting 1014 bp subcloned opd gene encoding the phosphotriesterase was
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isolated from an agarose gel. The opd gene was ligated with a 21 bp linker prepared by
digestion of pUC18 with BamH I and EcoR I. pET-3b was digested with BamH I to
yield a linear fragment, which was purified on a 1% agarose gel. The linearized pET-3b
fragment was combined with the linker modified opd gene (1:5 molar ratio) and
incubated with T4 ligase at 15 "C overnight. The resulting recombinant DNA plasmid
(designed pOL-1) was transformed into bacterial strain HBIOI. Colonies were screened
for insertion and insert orientation by digestion with BamH I (supposed to yield 1035 bp
and 4639 bp fragments) and EcoR I (supposed to yield 1524 and 4150 bp fragments).
pOL-1 was digested with Nde I and Pst I and the 2334 bp DNA fragment was isolated by
electrophoresis on a 1% agarose gel. pET-14b was digested with Nde I and Pst I and the
3399 bp DNA fragment was purified as above. The two gene fragments were incubated
with T4 ligase, and the ligation product was used for transformation of E. coli strain
BL21(DE3)pLysS. Transformants were selected and the DNA was verified by Ava I
digestion (supposed to yield fragments of 486, 1254 and 3993 bp). The resulting
plasmid (pOL-2) was partially digested with BamH I and the 5733 bp fragment was
incubated with DNA polymerase followed with ligation with T4 ligase to destroy the
BamH I site on the 3' end. The plasmid was designated pOL-3. A family of fragments
encoding the artificial domains was obtained from BamH I digestion of corresponding
recombinant plasmids^^-'^^- and the appropriated fragment was inserted in the BamH I
site of pOL-3. The resulting plasmids (pWD-X) contain a series artificial coding
sequences ligated in frame to the 5' end of the DNA encoding the modified
phosphotriesterase of Mulbry and coworkers^"*. Plasmids pWD-X were used to
transform E.coli strain BL21(DE3)pLysS.
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2.2.3 Expression of Hybrid Artificial Proteins
Cells containing the recombinant plasmid were grown in 2 liters of rich tryptone-
phosphate medium^^ supplemented with 200 mg/ml Ampicillin, 25 mg/ml
Chloramphenicol and 0.5 mM C0CI2 at 37 'C. When ODm reached 0.8-1.0. protein
expression was initiated by addition of IPTG to the medium to a final concentration of 0.4
mM. The growth temperature was then lowered to 30 X. After 6 hours, ODgoo reached
around 1.2-1.5, corresponding to 4-5 g of cells (wet weight) per liter of culture. Cells
were harvested by centrifugation at 5,000 x g for 10 minutes at 4 'C. Cell pellets were
resuspended in 40 ml of ice-cold sonication buffer (50 mM sodium phosphate buffer pH
8.0, 300 mM NaCl, 0.1 mM C0CI2 and 0.1% Triton X-100) and stored at -80 °C until
purification. Protein expression was monitored by SDS-PAGE at intervals of one hour
after induction. -
2.2.4 Protein Purification
After addition of DNase and RNase to final concentrations of 10 |ig/ml respectively,
the frozen bacterial cells were thawed at 37 °C for 90 minutes. (If cells didn't appear to
be lysed completely—i.e., if the solution was not viscous—cell mixtures were sonicated
on ice in 5 seconds pulse for 10 minutes.) The following steps were performed at 4 °C.
A clarified cell lysate was obtained after centrifugation at 12,000 x g for 30 minutes, and
added to 8 ml Ni-NTA agarose resin preequilibrated with sonication buffer. The mixture
was stirred gently for 2 hours. The resin was collected by centrifugation at 5,000 x g for
5 minutes and packed into a polypropylene column (1.6 cm i.d.). The column was
washed with sonication buffer until no significant decrease in OD280 was detected in the
eluent (approximately 120-150 ml). The resin was then washed with 80-100 ml of wash
buffer (50 mM sodium phosphate buffer, 300 mM NaCl, 0.1 mM C0CI2, 10% glycerol,
36
pH 6.0). Further washes were conducted with Tris buffer, pH 7.9 containing low
concentrations of imidazole: 50 ml MCAC-0 buffer (20 mM Tris Cl, pll 7.9. 500 niM
NaCl, 0.1 mM C0CI2), 50 ml MCAC-5 buffer (MCAC-0 buffer, 5 mM imidazole), 30 ml
MCAC-20 buffer (MCAC-0 buffer, 20 mM imidazole).
The target protein was cluted with 4x3 ml MCAC-2(X) buffer (most target protein in
3rd and 4th fractions). The eluent was immediately subjected to buffer exchange into
HliPliS buffer (50 mM llliiniS, pll 8.5, 10% glycerol and 0.1 mM C0CI2) using a Bio-
Rad prepacked licono-Pac lODG column. The protein solutions were combined and
loaded on a Sephadex DIvAIl A-5() column (5.0 x 1.6 cm). The column was washed with
40 ml IIEPES buffer, 60 ml IlF.PnS-.SO (IlF.Pl-S buffer containing 50 mM NaCl), and
elutcd with 40 ml volumes of I lI^PlvS- 100 buffer and I lI':PnS-3()() buffers. The eluted
fractions were concentrated to ca. 1 mg/ml by ultrafiltration using a Cenlriprep 10 unit.
Proteins were analyzed by electrophoresis on 12% wSDS-polyacrylamide gel. Quantitative
measurements of protein concentration were made achieved by the Bradford method with
BSA as standard.^"
2.2.5 Fnzyme Activity Measurements
For the soluble proteins, enzymatic activity was measured using paraoxon as the
substrate in 150 mM CI IFS buffer at pi 1 9.0. The reaction was monitored through the
absorbance of the product /?-nitrophenolate anion (Xmux 400 nm, c=l7,()(X) cm ') on a
Hitachi Model 26(X) spectrophotometer. One unit of activity is defined as the amount of
enzyme that hydrolyzes 1 ^imol of paraoxon per minute. I-or the immobilized enzymes,
the substrate of interest was treated with the hybrid i)r()lein (cf. following
section) and
then suspended in 1 50 mM CI IFS buffer at pi I 9.0. Fnzyme activity was monitorai
through the absorbance at 400 nm upon addition of substrate paraoxon.
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The initial reaction velcx^ity was measured for paraoxon with concentrations ranging
from 0.025 to 1.5 mM. The kinetic constants were determined from the Michaelis-
Menten equation:
V = VmS/(Kn, + S)
where V is the initial velocity, Vm the maximal velocity, S the substrate concentration and
Km the Michaelis constant^^ The kinetic constants were determined by at least three
independent measurements, with twelve paraoxon concentrations in each measurement.
The rate of enzymatic hydrolysis of paraoxon (1 mM) was determined for both the
soluble and immobilized forms of the phosphotriesterase at pH values from 4 to 1 1. The
pH value was controlled with the following buffers (100 mM sodium acetate buffer, pH
4.0, pH 5.0; 100 mM MES, pH 6.0; 100 mM MOPS, pH 7.0; 100 mM HEPES, pH 8.0;
100 mM CHES, pH 9.0; and 100 mM CAPS, pH 10.0 and pH 11.0)
2.2.6 Immobilization Procedure
Sephadex DEAE A-25, Sephadex DEAE A-50, QAE A-50 and Protein-Pak DEAE
were tested as substrates for immobilization of the hybrid artificial protein. The resins
were preequilibrated with HEPES buffer and dried at room temperature. The hybrid
protein solution was added to the resin and incubated at 4 °C overnight. The resin was
washed extensively with HEPES buffer until no activity was detected in the wash, and
then resuspended in HEPES buffer. The extent of immobilization was determined from
the difference between the amount of enzyme added to the suspension and the amount
present in the wash solutions. Protein adsorption was also determined from the
difference between the activity incubated with the beads and that in the wash.
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2.2.7 Activity upon Repeated Use
An aliquot of the immobilized hybrid protein on DEAE Sephadex A-50 was
resuspended in 1 50 mM CHES buffer, pH 9.0, in the filter of a Spin-X centrifuge u
(0.2 ^im). Paraoxon was added to start the hydrolysis reaction, and the supernatant
isolated after 5 seconds by centrifugation. The absorbance of the supernatant was
measured at 400 nm. The beads isolated in the upper filter were resuspended and
subjected to the same procedure through 10 cycles.
2.3 Results and Discussion
2.3.1 Construction of the Bacterial Expression Systems
Genes encoding a series of artificial proteins ligated to the 5' end of the opd fragment
(which corresponds to residue Asn of the modified phosphotriesterase^"^) were
constructed through recombinant DNA technology (Figure 2.3). A short linker encoding
9 amino acid residues was derived from the polylinker region of pUC18 and used to fuse
the two fragments of genes in frame. The amino terminus of the phosphotriesterase was
chosen for fusion with the artificial domain based on previous kinetic studies of the
enzyme: Mulbry and Kams reported that the enzyme remained highly active with N-
terminal deletion of 33 amino acids and replacement with the first 5 residues from lacZ,
while C-terminal modification resulted in complete loss of enzymatic activity^.
The crystal structure of the phosphotriesterase, which was solved recently"*^'
provides insight into the enzyme's tolerance of N-terminal modification. The enzyme
was shown to be a homodimer of a/p barrel subunits, with eight parallel p-strands
forming the barrel and flanked on the outer surface by 14 a-helices. The active site of
each subunit is located on the C-terminus of the p-barrel and contains two equivalents of
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zinc as a binuclear metal center separated by 3.3 A. Upon formation of the dimer
structure, the two active sites are located towards the interface. The two N termini lie
near the outer surface in an asymmetrical manner and are away from the active sites. The
crystal structure of the enzyme provided support of our design of the hybrid artificial
proteins, in that addition of the artificial domain at the N-terminus, which might not
significantly disturb the structure of the enzyme and might therefore result in preservation
of enzymatic activity.
A series of genes varying in length from 1641 to 2073 bp (depending on the length of
the artificial domain) were cloned in expression vector pET-14b, a T7 phage promoter-
driven system originally developed by Studier and colleagues^'^. The recombinant
plasmids were designated pWD-X, where X reflects the sequence of the artificial domain.
For example, "3PEG16" represents artificial domain [(AG)3PEG]i6, "3EG36" depicts
artificial domain [(AG)3EG]36. Restriction analysis was conducted to verify insertion and
correct orientation of the insert in the plasmid constructs (Figure 2.3). The DNA
fragments resulting from BamH I digestion were 5730 bp (all plasmids) and 504 bp
(pWD-3PEG16), 600 bp (pWD-4PEG16), 936 bp (pWD-3EG36), 612 bp (pWD-
4EG18), 912 bp (pWD-4EG28), 576 bp (pWD-5EG14) and 660 bp (pWD-6EG14),
respectively. Ava I digestion yielded fragments of 486 bp, 4013 bp (all plasmid) and
1735 bp (pWD-3PEG16), 1831 bp (pWD-4PEG16), 2167 bp (pWD-3EG36) , 1843 bp
(pWD-4EG18), 2143 bp (pWD-4EG28), 1807 bp (pWD-5EG14) and 1891 bp (pWD-
6EG14) in length respectively. The plasmids were used to transform E.coli strain
BL21(DE3) pLysS, the host for target protein expression.
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2.3.2 Expression of the Hybrid Artificial Proteins
2.3.2.1 HAP3EG36
The first hybrid artificial protein experiments were carried out in E. coli strain
BL21(DE3) pLysS transformed with the recombinant plasmid pWD-3EG36. The hybrid
protein, designated HAP3EG36, contains the phosphotriesterase fused to the artificial
domain [(AlaGly)3GluGly]36. The target protein was expressed under control of a strong
bacteriophage T7 promoter recognized by the highly active T7 RNA polymerase. The
rate of cell growth was monitored in comparison with control experiments using the same
strain but without induction, strain BL21(DE3) pLysS pOL-3 (PTE insertion control) and
strain BL21(DE3) pLysS pET-M18^^ (artificial protein insertion control) conducted in
tandem (Figure 2.4). The rate of cell growth prior to induction was normal in all cases,
but declined in BL21(DE3) pLysS pWD-3EG36 and BL21(DE3) pLysS pET-M18
shortly after induction. The decrease of growth rate in BL21(DE3) pLysS pET-M18
(which produces the polypeptide [(AG)3EG]36) was reported previously-^^. The growth
behavior of cells that express the hybrid protein very much resembles that of the strain
producing the artificial domain alone.
The reduction in the growth rate was appears to depend on the accumulation of a new
protein (HAP3EG36) in BL21(DE3) pLysS pWD-3EG36, as the same strain without
induction continued to grow at the normal rate. On the other hand, BL21(DE3) pLysS /
pOL-3, which produces the recombinant phosphotriesterase (PTE), continued to grow at
the normal rate after induction, indicating a lack of severe toxicity of the
phosphotriesterase in the BL21(DE3)pLysS strain. Gel electrophoresis of the crude cell
extracts revealed a new protein of apparent molecular weight ca. 90,0(X) (Figure 2.5),
much higher than the actual molecular weight (64,050) of the hybrid protein. It is known
that poly(AG)3EG migrates anomalously slowly under similar electrophoretic
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conditions'^. This behavior has been attributed to the bias of the sequence of the artificial
domain towards amino acids of relatively low molecular weight, and to the high acidity of
this domain22. Therefore it is not too surprising that the hybrid protein, containing the
artificial polypeptide, showed the same anomalous migration. HAP3EG36 was stable
and showed no degradation during protein synthesis as determined by 35s methionine
labeling in a pulse-chase protocol (Figure 2.6).
Whole cell lysates containing HAP3EG36 showed enzymatic activity. Paraoxon was
added to protein solution in 150 mM CHES buffer, pH 9.0. The reaction mixture was
subjected to successive wavelength scans as a function of reaction time (Figure 2.7).
The enzymatic hydrolysis product p-nitrophenolate, as monitored by absorption at 400
nm, increased with time as the hydrolysis reaction proceeded.
2.3.2.2 Cell Growth Conditions for Improvement of Hybrid Protein Production
When the hybrid artificial protein HAP3EG36 was expressed at 37 °C in 2xYT
medium, SDS-PAGE analysis showed that a large portion of the hybrid protein formed
inactive, insoluble protein aggregate—an inclusion body. Inclusion body formation is
probably due to the enzyme domain; repetitive polypeptides [(AG)3EG]36 were
expressed in soluble form-^^, while the phosphotriesterase was shown largely to form
inclusion bodies when expressed in the pET vector.
One method to reduce inclusion body formation was reduction of cell growth
temperature'^. The hybrid proteins were expressed at 30 °C in an attempt to reduce
inclusion body formation. Although the growth was slower than that at 37 °C, the HAP
produced at 30 °C was more soluble and showed higher enzymatic activity in whole cell
lysate. The specific activity of HAP3EG36 expressed at 30 °C was four times greater
than that of samples prepared at 37 °C (Table 2.1).
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The cell growth medium also affected the location of proteins expressed in E. coli. It
has been reported previously that an enriched growth medium (tryptone-phosphate) could
reduce inclusion body formation in the pET protein expression system^^. Indeed
HAP3EG36 was expressed with higher specific activity when grown in tryptone-
phosphate medium up to 9 hours after induction, as compared to other rich media (2xYT
or 4xYT, Table 2.2). The higher activity could also be a result of increased target protein
production, as SDS-PAGE showed a significantly higher level of expression in tryptone-
phosphate medium compared to 2xYT.
The phosphotriesterase is a zinc-containing metalloenzyme in its native form^. It
was reported that supplementing of the growth medium with 1 mM Co2+ ion increases
the specific activity of the enzyme expressed in E.coli^ For BL21(DE3) pLysS cells,
we found that 1 mM or 0.75 mM Co2+ was too toxic for efficient cell growth and the
optical density was limited to 0.8. Different concentrations of Co^^ ion in the growth
medium were tested for expression of HAP3EG36. The specific activity of the hybrid
protein differed significantly with cobalt concentration, as shown in Table 2.3. The
highest enzymatic activity was achieved with 0.5 mM Co^'*' ion in the growth medium.
However, target protein production did not seem to vary strongly with the concentration
of Co2+ in the range from 0 to 0.5 mM, as judged from gel electrophoresis. This
suggests that effect of the cobalt ion is to increase the fraction of active protein by yielding
higher enzymatic activity of the soluble fraction and/or by reducing inclusion body
formation. This argument is supported by previous reports that metal ions in
metalloproteins can favorably shift the folding/unfolding equilibrium and enhance
thermodynamic stability by binding with higher affinity to the folded state than to
unfolded or partially folded states^^*^^.
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2.3.2.3 Expression of a Family of Hybrid Artificial Proteins
As mentioned in the introduction, the motivation for exploring hybrid artificial
proteins was to enable material scientists to harness biological function in a controlled and
systematic manner. Toward this end, a family of hybrid artificial proteins was produced
to gain control over chemical and structural properties of the artificial domain. The
proteins prepared contained the phosphotriesterase domain linked at its N-terminus to
artificial protein domains with sequences la-b and 2a-e respectively, where
-[-(AlaGly)xProGluGly-l-n 1 a: x=3 n=16
b: x=4 n=16
-[-(AlaGly)xGluGly-]-n 2 a: x=3 n=36
b: x=4 n=18
c: x=4 n=28
d: x=5 n=14
e: x=6 n=14
All of the target proteins were expressed in Escherichia coli under control of the T7
phage promoter derived from pET-14b. The growth rates of all of the expression strains
were depressed shortly after induction, correlated with the artificial protein synthesis
(Figure 2.8). Protein expression was analyzed by gel electrophoresis of whole cell
lysates, as shown in Figure 2.9. All the proteins, as with HAP3EG36, showed the
anomalous electrophoretic migration characteristic of the artificial polypeptides. The
production of hybrid artificial protein varied significantly with the sequence and chain
length of the artificial domain. Most obviously, hybrid proteins containing the
(AG)xPEG series of artificial domains were produced more efficiently than those in the
(AG)xEG series, as observed previously for the artificial polypeptides alone^^- The
artificial repetitive polypeptides seemed also to affect proper folding of the hybrid
44
proteins. For the (AG)xEG variants, artificial domains of longer chain length were
shown to produce more soluble target proteins than the shorter sequences.
From the above results, it appears that cell growth and synthesis of the hybrid
proteins parallel the behavior similarly with the artificial domains. Many N-terminal
fusions are used to improve heterologous protein expression. Therefore it is not too
surprising that the N-terminal artificial domain determined the biosynthesis properties of
the hybrid. Such observations will be helpful in future hybrid protein designs.
2.3.3 Purification of the Hybrid Artificial Proteins
Hybrid artificial protein HAP3PEG was chosen for further studies as the protein
showed good expression in E. coli, almost comparable with that of the recombinant
phosphotriesterase alone (Figure 2.10). Protein purification was conducted with the
soluble fraction of the lysate. Since there were six consecutive histidine residues attached
to the N-terminus of the hybrid protein, the target protein was purified by immobilized
metal chelate affinity chromatography. When the whole cell lysate was loaded onto a Ni-
NTA resin, most E. coli proteins passed directly through the column but the target
protein was adsorbed (Figure 2.1 1). After extensive washing, the target protein was
eluted with a buffer solution containing 200 mM imidazole. The imidazole competed with
histidine for the binding sites on Ni and subsequently displaced the target protein from the
column.
Imidazole was found to inactivate the hybrid protein rapidly; 95% of the activity of the
hybrid protein were lost after incubation in 200 mM imidazole for 24 hours. A size
exclusion column was used to desalt and to separate the hybrid protein from imidazole in
the elution buffer. The hybrid protein was further purified by ion exchange on DEAE-
Sephadex to homogeneity, judging from the amino acid analysis (Table 2.4) and SDS-
PAGE gels (Figure 2.11). The procedure gave 2.6 mg of HAP3PEG 1 6 per liter of cell
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culture (approximately 4-5 g of wet cell weight) with a 37 fold purification (Table 2.5).
HAP3PEG16 exhibited specific activity of 3540 units/mg toward hydrolysis of paraoxon,
while the recombinant phosphotriesterase (PTE) showed 5630 units/mg. Therefore the
hybrid artificial protein, containing additional artificial polymeric domain of 13969 Da,
exhibited 63% specific activity of PTE. When normalized with molecular weight, the
activity of the hybrids is 85% of that of the recombinant PTE.
Phosphotriesterase from Pseudomonas diminuta has been purified from the a
baculovirus expression system with a yield of 2.7 mg target protein from 8 grams of cells
(wet weight)^^. The specific activity of the enzyme was 3,200 units/mg. Subsequently,
Omburo and coworkers purified a modified phosphotriesterase expressed in E. coli
,
with
deletion of the 33 N-terminal amino acids and replacement with the first 5 lac Z residues
(Met-Ile-Thr-Asn-Ser-) followed by the Gly34 enzyme residues^, with reported yield of
298 mg proteins from 160 g of bacterial cells (wet weight). The specific activity of the
enzyme was 8020 units/mg using 1 mM Co^"*" in the growth medium. For our system,
however, we could only use 0.5 mM Co^"*"; 1 mM or 0.75 mM Co^"*" was too toxic for
BL21(DE3) pLysS cells to grow efficiently and the optical density was limited to 0.8.
The decreased activity of the recombinant PTE prepared in this work might be a result of
lower concentration of Co^"*" in the growth medium. It could also be attributed to the
additional 40 amino acid residues at the N-terminus of the reported enzyme; the
recombinant PTE has a molecular mass of 40,247 Da compared to 34,524 Da expressed
in E.coli previously. The activity of the recombinant PTE is 82% of that of the reported
enzyme when normalized with molecular weight of the two proteins.
The hybrid proteins represents only about 3% of the whole cell proteins, calculated
from the 37-fold of purification. SDS-PAGE gel, however, showed at least 25% of
whole cell protein is the target protein judging from the band intensity in Figure 2.10.
Fractionation of the cell lysate and electrophoretic analysis indicated inclusion body
formation of the expressed proteins. The majority of the target protein was produced in
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an insoluble and inactive form with only a small fraction present in the soluble lysate.
The production of soluble protein was increased by using lower cell growth temperature
at 30 'C and extra rich tryptone-phosphate medium. Protein purification was also
conducted on the insoluble fraction of the lysate by immobilized metal chelate affinity
chromatography using a denaturing protocol from Qiagen. Attempts to refold the purified
inactive hybrid from the inclusion body by dialysis with gradually decreasing
concentrations of urea in 50 mM HEPES buffers was not successful. Reactivation of the
insoluble hybrid protein remains to be done in the future for potentially higher yield of the
hybrid proteins.
2.3.4 Kinetic Characterization of the Hybrid Artificial Proteins
2.3.4. 1 Enzymatic Activity of the Hybrid Artificial Proteins
Other hybrid artificial proteins also showed enzymatic activity with respect to catalytic
hydrolysis of paraoxon. Of all the proteins constructed, HAP3PEG16 gave the highest
specific activity (3540 units/mg). The purified HAP4EG18 and HAP4EG28 yielded
specific activities of 660 and 360 units/mg respectively, suggesting that hybrids with
smaller artificial domain was more enzymatically active.
2.3.4.2 Initial Velocity of the Enzymatic Reaction
Purified HAP3PEG16 was subjected to kinetic study using paraoxon as substrate.
The progress of the catalytic reaction is shown in Figure 2.12. The hydrolysis of
paraoxon was initiated upon addition of the hybrid protein and monitored by measuring
the increase in absorbance at 400 nm arising from the hydrolysis product p-
nitrophenolate. Initially the product formation increased linearly with time, from which
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the initial slope can be estimated to yield an initial velocity^^. As the reaction proceeded,
the fall in substrate concentration or/and product inhibition resulted in a velocity decrease
with time. All of the kinetic studies in this work were based on measurement of the initial
velocity, which is hereinafter referred to as "the reaction velocity".
2.3.4.3 Effect of Hybrid Protein Concentration
The enzymatic hydrolysis of paraoxon was measured at different concentrations of
HAP3PEG16 using a large excess of substrate (Figure 2.13). Under such conditions,
the velocity was therefore proportional to the protein concentration^^
v = k[E] (2.1)
The reaction velocity, determined from the initial slope of the absorbance vs. time curve,
indeed showed a linear correlation with the hybrid artificial protein concentration (Figure
2.14)
2.3.4.4 Effect of Substrate Concentration
The reaction velocity was measured at different concentrations of paraoxon with a
fixed amount of the hybrid protein. As shown in Figure 2.15, the reaction velocity
increases initially with substrate concentration and gradually levels off. The curves can
be fit with the Michaelis-Menten kinetic equation and show very good agreement. This
result indicates that the hybrid follows the same Michaelis-Menten mechanism as that
reported for the phosphotriesterase^. The mechanism, first developed by Michaelis and
Menten in 1913, has been the foundation the greater part of enzyme kinetics^^
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According to the theory, the enzyme first forms a complex with its substrate and this
subsequently breaks down giving the free enzyme and the products of the reaction.
E+ S = ES ^ E+ P (2 2)
Under a steady state assumption where the concentration of enzyme-substrate complex
remains constant, the reaction velocity can be obtained as:
V = Vm[SJ / (Km + [SJ) (2.3)
where v is the initial velocity, Vm the maximal velocity, S the substrate concentration and
Km the Michaelis constant. At saturating substrate concentrations, when [S] » Km,
V - Vm = k[E] (2.4)
which would give equation 2.1, in agreement with the results shown in Figure 2.14.
According to the Michaelis-Menten equation, if 1/v is plotted against 1/S, a straight
line should be obtained, corresponding to the reciprocal form of the equation
i = J_ +]^.± (2.5)
V Vo, v. [S]
Such plot, (Lineweaver-Burk plot)^^ indeed gave linear correlation for the hybrid protein
and for the recombinant PTE (Figure 2.16). The kinetic constants were obtained from the
plots (Table 2.6). The catalytic rate constant (kcai) of the hybrid was shown to be 66% of
the value for PTE. The Km value of the hybrid protein is lower than that of the
recombinant PTE, suggesting a more favored enzyme-substrate complex formation for
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the hybrid than for the enzyme alone. As a result, kcat/Km for the hybrid is 81% of that
of the recombinant enzyme. Since the products of the hydrolysis reaction are both
anionic in the reaction buffer at pH 9.0, it is possible that expulsion between the anionic
artificial domain and products encouraged leaving of the products from the enzyme active
site and therefore shift the equilibrium of the enzyme-substrate complex formation.
The decrease of enzymatic activity in the hybrid protein might be due to partial
disturbance of protein folding of the enzyme domain by the artificial partner. The
sequence of HAP3PEG16 was subjected to computer simulation. The obtained
secondary structure of the enzyme domain was compared with crystal structure of the
enzyme determined by X-ray diffraction analysis-''^. The computer prediction of the
hybrid showed preservation of 5 out of 8 P strands, mostly in the latter half of the
sequence. Most of the a-helical structure of the enzyme domain was disturbed, with only
6 out of the 14 helices predicted, all at the C teiininus of the enzyme. Detailed study of
the secondary structure of the two domains of the hybrid could be done in the future by
circular dichroism and two dimensional NMR.
Nevertheless the absolute value of catalytic constant, kcat, of 2500 s"^ indicated the
hybrid was sufficiently active for catalytic hydrolysis of paraoxon. The pH profile of the
hybrid protein is similar to that of the recombinant PTE (Figure 2.17), suggesting that the
ionizable group important for activity of the enzyme was not significantly affected by the
artificial fusion.
2.3.5 Immobilization of Hybrid Artificial Proteins
Given the multiple carboxylate functional groups from the glutamate residues of the
artificial domain, the hybrid proteins were expected to be selectively adsorbed to cationic
surfaces through electrostatic interactions. Computer simulation of HAP3PEG16 showe
that the artificial domain contained 1 1 glutamic acid residues that are entirely
accessible tc
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solvents (with reliability >70%); around 70% of glutamic acid residues from the artificial
domain were on the outer surface and gave the anionic character of the hybrid protein
.
Computer simulations also showed that the artificial domain is in random coil structure,
with the probability of coil more than 80%.
Affinity toward DEAE-Sephadex A-50, an anionic exchange resin, was tested for
both HAP3PEG16 and the recombinant phosphotriesterase (PTE). Purified proteins
were loaded onto DEAE-Sephadex column and protein was eluted with 50 mM HEPES
buffer, pH 8.5 containing different concentrations of sodium chloride. Elution of the
hybrid and the enzyme was monitored by the enzymatic activity of the eluent. Elution of
HAP3PEG required 1(X) mM NaCl while PTE was found in the first elution fraction,
without added salt (Figure 2.18). These results clearly demonstrate that the hybrid bound
to the cationic surfaces through the anionic artificial domain; the enzyme domain itself
showed little binding. The isoelectric point (PI) of the hybrid is calculated to be 6.02,
while that of the recombinant phosphotriesterase is 8.7. At pH 8.5 (where the
immobilization was done), the anionic form of hybrid protein is dominant; on the other
hand, the recombinant enzyme is essentially neutral. The difference of PI values of the
hybrid and the enzyme explains the selective binding of the hybrid to cationic surfaces.
Other hybrid artificial proteins also showed selective adsorption to cationic surfaces.
The ionic interaction was probed using whole cell lysates containing hybrid proteins with
varied number of anionic groups on the artificial domain. The HAP3PEG16 cell lysate
showed different affinity with the resin than the pure protein, with most protein eluted at
200 mM NaCl (Figure 2.19). HAP3EG36 exhibited ion exchange behavior similar to
that of HAP3PEG16, although it contained 20 additional glutamic acid residues on the
artificial domain. Proteins with same repeating sequence but different chain length, such
as HAP4EG18 and HAP4EG28, also didn't seem to show significant differences in
binding to DEAE Sephadex. However, with the same number of charges but different
number of hydrophobic amino acid residues on the artificial domain, as in the case of
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HAP3PEG16 and HAP4PEG16, there is a significant difference in ion exchange
behavior. I1AP4PEG 16 showed a bimodal elution at 100 niM and 300 mM NaCl
respectively, which is interesting and puzzling. The reason for the bimodal elution is not
clear although it is suspected there is a nionomcr-dinier equilibrium of HAP4PEG16.
A variety of cationic resins functionalizctl with primary, tertiary and quaternary amino
groups were studied for hybrid protein immobilization (Table 2.7). Both PTE and
HAP3PEG16 bind to silica beads and to silica coupled with aminopropyl
trimethoxysilane under a variety of pli conditions. The hybrid protein was selectively
adsorbed on positively charged hydrophilic surfaces through ionic interaction; hydrophilic
surfaces without amino functional groups did not adsorb the hybrids. Another direct
evidence of ionic interaction arises from the observation that hybrids were not
immobilized on amino surfaces when polyglutamic acid (MW 50(K)) and polystyrene
sulfonate was added to the incubation buffer.
The immobilized HAP on DEAE-Sephadcx resin exhibited low catalytic activity for
hydrolysis of paraoxon. The relative activity of the immobilized HAP3PEG16 was less
than 10% of that of the soluble proteins. Kinetic analysis gave a K,n value of KXM) |iM
for the immobilized enzyme, suggesting a large diffusion effect"*". Considering that the
hybrid protein was highly active in solution, a decreased diffusion rate of substrate upon
immobilization will significantly lower the apparent enzymatic activity.
The relative activity of immobilized HAP3PEG 16 was increased substantially with
decrease in resin particle sizes ranging from 0.8 |im to 2(X) |im in diameter, as shown in
Table 2.8. With Protein-Pak DMAE, a polyacrylate based anionic exchange resin 15 ^im
in diameter, the relative activity (kcai) of the immobilized hybrid protein was 72%
compiu-ed to the soluble fonii (Table 2.6). The small resin particles provided more
surface area in contact with solution and therefore generated less steric hindrance for the
diffusion of the substrate from bulk solution to the solid support. The internal diffusion
effect was reduced when the protein was immobilized on the outer surface of the resin
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instead of within the pores. The relative activity of the immobilized HAP3PEG 16 on
Protein-Pak DEAE was increased with more resin used for immobilization (Table 2.9)
and reached maximum at 3 units per mg of beads, corresponding to approximately
monolayer coverage of the hybrid on the outer surface of the resins. The diameter of the
hybrid is 80 A, estimated from addition of diameter of the enzyme subunit (50 A^^- '*^)
and diameter of the artificial domain (30 A, end to end distance as ramdom coil
structure"*^
)
A kinetic study of HAP3PEG16 immobilized on Protein-Pak DEAE microspheres
was conducted. The Lineweaver-Burk plot indicated that the immobilized hybrid also
followed Michaelis-Menten kinetics. The value of kcat for the immobilized hybrid was
shown to be 1800 s ^ yielding 72% relative activity comparing with the soluble form
(Table 2.6). The Km of the immobilized protein is 5 times greater than that of the soluble
form, attributed to the diffusion hindrance of substrate to the heterogeneous active center
upon protein immobilization (compared to the diffusion of substrate to the active site of
the soluble enzyme). Another factor for the increase in Km is the affinity of product p-
nitrophenolate to the cationic matrix.
2.3.6 Application of Immobilized HAP in an Enzyme Reactor for Pesticide Detoxification
Application of the immobilized hybrid artificial protein was demonstrated in a column
reactor for rapid hydrolysis of organophosphate pesticides. HAP3PEG16 and
recombinant PTE were loaded on DEAE Sephadex A-50 columns, and after extensive
wash, paraoxon was loaded on the column. The yellow hydrolysis product /?-
nitrophenolate appeared rapidly on the column containing immobilized hybrid artificial
proteins; the column that contained recombinant PTE showed no hydrolysis reaction since
the enzyme couldn't bind to the resin and was washed off the column (Figure 2.20). The
enzyme column showed good stability with repeated uses, as 90% of activity remained
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after 10 cycles of use (Figure 2.21). Furthermore, as demonstrated previously, the
protein can be eluted at high ionic strength; providing easy and economical regeneration
of the column reactor when the immobilized protein loses activity. Other potential
applications of the immobilized hybrid protein include HPLC column devices for
pesticide detection, as Protein-Pak DEAE is an HPLC resin. Given the broad substrate
range of the phosphotriesterase, the immobilized hybrid proteins are potentially useful for
detection and detoxification of organophosphate pesticides and chemical warfare agents.
2.4 Conclusions
We have developed novel hybrid artificial proteins in which artificial repetitive
polypeptides were fused with a natural protein or domain. Such hybrids will allow
materials scientists to harness biological functions in the form of biocatalytic surfaces,
reactive membranes, protein arrays and enzyme networks. As a model system, we
produced hybrid artificial proteins as "sticky enzymes" where the artificial domain served
to bind to surfaces while the natural domain performs catalytic activities. A family of
hybrid artificial proteins containing the artificial sequence motif [(AlaGly)nXGly]ni (X =
ProGlu or Glu) and the phosphotriesterase was synthesized through recombinant DNA
technology. We explored the behavior of hybrid artificial proteins with artificial domains
with systematically varied sequence and chain length. The hybrid proteins exhibited
excellent catalytic activity for rapid hydrolysis of paraoxon. For one of the hybrid
variants (HAP3PEG16), the kcat value was 2500 s'K 66% of the value of the
recombinant phosphotriesterase (PTE). The Km value of the hybrid protein was lower
than that of PTE, and results in kcai/Km 81% of the value of PTE. The hybrid artificial
proteins were selectively adsorbed on cationic surfaces through electrostatic interaction
with the anionic artificial domains. The immobilized hybrid protein remained highly
active, with 72% of kcat of the soluble form. The immobilized hybrid was used in a
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column reactor for detoxification of the organophosphate pesticide paraoxon. Hybrid
artificial proteins, combining materials properties of artificial polypeptides with the
biological functions of natural proteins, provide a simple route to self-assembled
biocatalytic surfaces.
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Table 2.1 Effect of growth temperature on enzymatic activity of HAP3EG36^
Time after induction (hours)
0.5 1 2 3 4
Specific Activity (Units/mg protein)
37 T 0.06 0.50 0.52 0.38 0.45
30 T 014 027 L34 LOT 1,92
^Activity was measured with whole cell lysate; cells were grown in 2xYT
medium.
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Table 2.2 Effect of growth medium on activity of HAP3EG36^
Media
Time after Induction (hours)
3 6 9
Specific Activity (Units/mg protein)
2xYT»> 1.2 1.27 0.17
4 xYTc 1.33 1.62 0.38
Tryptone-phosphate^ 1.95 3.21 0.80
^Activity was measured with whole cell lysate; cells were grown at 30 'C after induction.
*'1.6% bacto-tryptone, 1.0% yeast extract, 0.5% NaCl
c3.2% bacto-tryptone, 2.0% yeast extract, 1.0% NaCl
d2% bacto-tryptone, 0.2% Na2HP04, 0.1% KH2PO4, 0.8% NaCl, 1.5% yeast extract,
and 0.2% glucose.
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Table 2.3 Dependence of activity of HAP3EG36 on concentration of cobalt ion in the
growth medium^
Co 2+
Concpntratinn
(mM) 60
Time after induction (minutes)
120 180 240
(units/mg of protein)xlO(X)
0 5.8 5.8 6.0 8.0
0.25 8.4 36.0 68.0 140
0.5 11.0 9.6 550 600
1.0 10.0 7.3 19.0 6.2
a2xYT medium, at 30 'C.
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Table 2.4 Purification of hybrid artificial protein HAP3PEG16
Fraction Total protein Total activity
UflllS X I Lr
Specific
activity
Yield Purification
fnldJOIU
Cell lysate* 612 5.85 96 100 1
Ni-NTA 23.6 3.95 1670 67.5 17.5
DEAE A-50 5.2 1.84 3540 32 37
^ Isolated from 2 liter of culture grown to a cell density of OD600 = 1.280 and 4.5 g/L wet
cell weight; the cells were grown at 30 after induction
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Table 2.5 Amino acid composition of the HAP3PEG163
Amino acid Predicted'' Anal vsis*^
Ala 16.4 16.0
Gly 18.5 19.3
Glx(Glu+Gln) 8.4 8.8
Asx(Asp+Asn) 5.3 5.5
Phe 2.9 3.1
His 2.8 2.7
De 4.8 4.1
Lys 1.7 2.0
Leu 6.5 6.0
Met 2.2 2.1
Pro 6.6 7.0
Arg 6.1 6.3
Ser 6.5 6.8
Cys 0.4 0.04
Thr 4.6 4.7
Val 4.4 4.0
Tyr 1.3 1.4
Trp 0.7 ND
* Measurements based on mol%
^Deduced from the DNA sequence encoding the protein
^Values were obtained by calculations based on molecular weight
of 53,884, derived from amino acid sequence
^ND: not determined
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Table 2.6 Kinetic constants
Proteins kcat(sec-i) Km (|iM) kcat/Km
(10^ M-' s-i)
HAP3PEG16 25001280 120 ±40 2.1
PTE 3880 ±220 150 ±30 2.6
Immobilized HAP** 1800 ±200 870 ±50 0.21
Measurements based on HAP3PEG16 immobilized on Protein-pak DEAE resins
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Table 2.7 Immobilization of proteins on different surfaces^
pH beads'^ PTE HAP3PEG16
6.8
Si-OH + -1-
Si-NH2 + +
8.5
Si-OH + +
Si-NH2 + +
11
Si-OH + +
Si-NH2 +
NaOH
Si-OH
—
—
Si-NH2
— —
8.5 Streamline
DEAE + +
8.5 Sephadex — —
8.5 polyacrylamide — —
8.5 Sephadex-
DEAE
— +
8.5 Sephadex-QAE +
8.5 Protein-PakDEAE
+
aProteins were incubated with beads at indicated pH for 2 hours at 4 °C. The beads were
washed extensively with 50 mM HEPES buffer, pH 8.5, before measurement of activity
in the wash and of the beads for hydrolysis of 0.5 mM paraoxon. Activity observed on
beads is represented as "-»-" and no activity on beads (up to 60 seconds) is represented as
ft ti
•
bSi-OH are silica microspheres of 0.8 |im in diameter. Si-NH3 are Si-OH coupled with
aminopropyl trimethoxysilane. Streamline DEAE is agarose beads functionalized with
DEAE (diethylaminoethyl) and contains small silica core.
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Table 2.8 Relative activity of immobilized HAP3PEG16
Beads DEAE QAE Streamline DEAE Silica- Silica Protein-
A-50 A-50 DEAE A-25 amino Pak
DEAE
Diameter
(^m) 200-300 200-300 100-200 0.8 0.8 15
Relative
Activity^ ^.0 6.5 9.1 9.3 59.8 56.4 72.0
(%)
^Based on ratio of kcat value of immobilized and soluble proteins.
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Table 2.9 Immohili/ation of 1 lAP on protcin-Pak 1)1{AI{^
Amount of i 2 4 6 8 10
resin (mg)
Relative 37 42 53 4^ ^2 39
Activity"^
(%)
»The amount of protein used is 25 units for each experiments. Immobili/.ation is
eonducted at 50 mM lIAPIiS buffer, pli 8.5. Details see lixperimenlal Section.
^^Based on ratio of specific activity of immobilized protein and soluble protein for
hydrolysis of paraoxon.
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Natural Domain
mmm
Artificial Domain
Figure 2.1 A schematic illustration of the design of hybrid artificial proteins
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Linker:
5'
BamHI
gatccccgggtaccgagctcg
gggcccatggctcgagcttaa
EcoRI
N B
1. Linker
2. T4 Ligase Cut B
T4 Ligase
Restriction Enzvmes:
E - EcoR I, B - BamH I
N - Nde I, P - Pst I
1
Cut N, P
N
T4 Ligase
Cut N, P
L Partial digestion with BamHI
2. DNA polymerase
3. T4 ligase
Figure 2.2 Schematic diagram ofDNA construction for the expression of the hybrid
artificial proteins (a)
Continued next page
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Figure 2.3, continued
pOL-3
5730 bp
B
CutB
(B)
B
Restriction Enzvme
B -BamHI
T4 ligase
B
1. Transform into
BL21(DE3)pLysS
2. IPTG
pET-X
B
CutB
I I I I I I l~TT
la: 504 bp
lb: 600 bp
2a: 936 bp
2b: 612 bp
2c: 912 bp
2d: 576 bp
2e: 660 bp
Hybrid Artificial Protein (HAP)
(b)
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(1) (2) (3) (4) (5) (6) (7)
5686 b
4822 b
3675 b
2323 b
1929 b
1371 b
1264 b
702 b
Figure 2,3 Restriction analysis of recombinant plasmids containing genes encoding
hybrid artificial proteins, a) Lane 1: Lambda DNA-BstE II digestion.
Lanes 2-4: BamH I digestion of plasmids pWD-3PEG16, pWD-5PEG14,
pWD-6EG 14 respectively; Lanes 5-7 Ava I digestion of plasmids pWD-
3PEG16, pWD-5PEG14, pWD-6EG14 respectively.
Continued next page
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Figure 2.3, continued
(1) (2) (3) (4) (5) (6) (7) (8)
b) Lanes 1: Lambda DNA-BstE II digestion. Lanes 2-5: BamH I digestion
plasmids pWD-3EG36, pWD-4PEG16, pWD-4EG18, and pWD-4EG28
respectively; Lanes 6-8 Ava I digestion of plasmids pWD-4PEG16, pWD-
4EG18, and pWD-4EG28 respectively.
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0 0.5 1 1.5 2 2.5 3 3.5 4
Time After Induction (Hours)
Figure 2.4 Cell growth curve for expression of HAP3EG36. Cell growth is measured as
a change in optical density of the culture as a function of time.
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Negative Control Positive Control
[(AG)3EGl36 PTE HAP3EG36
0 60 0 60 120 0 120 0 30 60 90 120 150 180
Figure 2.5 Electrophoretic analysis of expression of hybrid artificial protein HAP3EG36
at various time point (minus) after the addition of IPTG. The first lane is
molecular weight markers (from top to bottom, 200, 97, 66, 43, 29 kDa)
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PTE
Time after
induction (min) 0 30
200 kDa-^
HAP3EG36
97 kDa—
66 kD
43 kDa—
29 kD
Figure 2.6. Pulse-chase experiments of PTE and HAP3EG36 in E.coli
by methionine labeling
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Wavelength (nm)
Figure 2.7 Wavelength scan of hydrolysis reaction of paraoxon by whole cell lysate
containing HAP3EG36
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0 0.5 1 1.5 2 2.5 3 3.5 4
Time after induclion (hours)
Figure 2.8 Cell growth curve for tiirget protein expression. Cell growth is measured as a
change in the optical density of the culture as a function of time.
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Figure 2.9 SDS-PAGE analysis of expression of a family of hybrid artificial proteins in
E. coli strain BL21(DE3)pLysS. a)Lane 1, molecular weight markers (from
top to bottom, 200, 97.4, 66, 45 kDa); lanes 2 - 6: HAP3PEG16 cell lysates
at 0, 1, 2, 3 and 4 hours after IPTG induction; lanes 7-11: HAP4PEG16
cell lysates at 0, 1, 2, 3 and 4 hours after IPTG induction, respectively.
Continued next page
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Figure 2.9, continued
1
_2_ 3 4 5 6 7 8 9 10 11
b). Lane 1, molecular weight markers (from top to bottom, 200, 97.4, 66, 45
kDa); lanes 2 - 6: HAP4EG18 cell lysates at 0, 1, 2, 3 and 4 hours after IPTG
induction; lanes 7-11: HAP4EG28 cell lysates at 0, 1, 2, 3 and 4 hours after
IPTG induction.
Continued next page
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Figure 2.9, continued
123456 789 10 11
^ * ^ ^
c) Lane 1, molecular weight markers (from top to bottom, 200, 97.4, 66, 45
kDa); lanes 2 - 6: HAP5EG16 cell lysates at 0, 1, 2, 3 and 4 hours after IPTG
induction; lanes 2-11: HAP5EG14 cell lysates at 0, 1, 2, 3 and 4 hours after
IPTG induction
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Figure 2.10 SDS-PAGE analysis of expression of HAP3PEG in E. coli strain
BL21(DE3)pLysS. Lane 1, molecular weight markers (from top to bottom,
97.4, 45 and 3 1 kDa); lanes 2-11: PTE and HAP3PEG cell lysates at 0, 1
,
2, 3 and 4 hours after IPTG induction, respectively.
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1 2 3 4 5 6
Figure 2.1 1 SDS-PAGE of purification of tiie hybrid artificial protein
HAP3PEG16. Lane 1, molecular weight markers (from top to bottom,
97.4, 45 and 31 kDa); Lane 2: cell supernatant; lane 3: fraction that
went through Ni-NTA column upon loading of cell supernatant; lane 4:
eluted fraction from Ni-NTA column with sonication buffer containing
200 mM imidazole; lane 5-6 eluted fraction from DEAL Sephadex A-50
column with 50 mM HEPES buffer, pH 8.5 containing 200 mM NaCl
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Figure 2.12 Reaction progress of catalytic hydrolysis of paraoxon by HAP3PEG16,
under conditions: [HAP] =0.15|ig/ml, [Paraoxon] =0.15 mM, 150 mM
CHES buffer, pH 9.0 at room temperature.
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gure 2.13 Effect of hybrid protein concentration on hydrolysis of paraoxon (0.5 mM),
in 150 mM CHES buffer, pH 9.0.
84
Amount of HAP3PEG16 (|ig)
Figure 2.14 Effect of hybrid protein concentration on initial reaction velocity
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ure 2.15 Effect of substrate concentration on initial reaction velocity, using
HAP3PEG16 (0.2 ng/ml) in 150 mM CHES buffer, pH 9.0
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/Figure 2.16 Lineweaver-Burk plot of the hybrid artificial protein HAP3PEG16 (•) and
the recombinant PTE (o).
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Figure 2.17 pH profiles of enzymatic activities of HAP3PEG and PTE, with 0.5 mM
paraoxon and 2 |ig/ml of proteins, in 150 mM CHES buffer, pH 9.0.
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Figure 2.18 Ion exchange chromatography of purified HAP3PEG and PTE using DEAE-
Sephadex A-50. The enzymatic activity of eluent is measured in 150 mM
CHES buffer, pH 9.0 and with 0.5 mM of paraoxon.
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Figure 2.19 Ion exchange chromatography of cell lysates of hybrid artificial proteins
using DEAE-Sephadex A-50.
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Figure 2.20 Application of immobilized hybrid artificial proteins in column reactors for
hydrolysis of paraoxon. Column on the left: HAP3PEG16, right: PTE, both
column contains DEAE Sephadex A-50.
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Figure 2.21 Stability of immobilized HAP3PEG under repeated use. Activity is
measured using 1.0 mM paraoxon in 150 mM CHES buffer, pH 9.0.
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CHAPTERS
IMMOBILIZATION OF RECOMBINANT PHOSPHOTRIESTERASE FOR RAPID
HYDROLYSIS OF ORGANOPHOSPHATE PESTICIDES
3.1 Introduction
Immobilized enzymes offer many advantages over soluble enzyme preparations
including reusability, compatibility with continuous catalytic processes and ease of
separation from the product in batch operations^ Many immobilized enzymes have been
reported to gain stability with respect to denaturation upon heating or prolonged storage.
In addition, immobilized enzymes have been proposed to serve as model systems to study
the mechanisms of enzymatic reactions in vivo^. Since the first commercialized
immobilized enzyme was introduced nearly 30 years ago^, numerous examples have been
developed for heterogeneous biocatalysis in industrial processes'*. More recently,
immobilized enzymes have been applied in biosensors and have found increasingly usage
in medicine, food quality control and environment monitoring^.
Organophosphorus compounds are widely used as pesticides for agricultural and
domestic applications, functioning as inhibitors of acetylcholinesterase^. However, these
compounds raise environmental concerns owning to their acute toxicity .
Organophosphate pesticides are highly toxic by all routes of exposure including
ingestion, dermal absorption and inhalation^. Repeated and prolonged exposure to
organophosphates may result in severe damage to the central nervous system.
Contamination by residual organophosphate pesticides has been found widely in soil,
ground water and vegetation^.
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Analysis of organophosphate pesticides is most frequently performed by gas
chromatography (GC) with element-selective or mass- selective detectors^. Although
residues can be detected with these methods to parts per billion (ppb), the required
instrumentation is expensive and the analysis is time-consuming. In contrast, enzyme
based biosensors, with the advantages of specificity, sensitivity, easy signal detection and
small size, would appear to offer special promise^^. An enzymatic method based on
inhibition of acetylcholinesterase activity has been studied intensively for
organophosphate detection^ ^ However, the measurement involves at least a two-step
process (inhibition and activity assay), and reactivation of the enzyme.
The phosphotriesterase originally found in Pseudomonas diminuta MG and
Flavobacterium sp., provides a good candidate for use in the construction of biosensors.
This enzyme is capable of direct, specific and fast determination of organophosphate
pesticides. The phosphotriesterase hydrolyzes a wide variety of organophosphates
including some of the most commonly used organophosphate pesticides and deadly nerve
agents^^. The catalytic hydrolysis reaction has been studied extensively by Raushel and
coworkers^ who have demonstrated that substrates such as paraoxon (diethyl-p-
nitrophenyl phosphate), can be hydrolyzed at rates near the diffusion limit'^. The crystal
structure of the enzyme suggests that the phosphotriesterase consists of a homodimer of
39 kDa subunits^^. The active site of each enzyme subunit contains 2 equivalents of zinc
separated by 3.3 A as a binuclear metal center. The phosphotriesterase has been cloned
and expressed in E.coli with deletion of the 33 N-terminal amino acids^^- Hydrolysis
of paraoxon produces a brightly colored phenolic product with an extinction coefficient of
17,000 M-^cm-i at 400 nm, which can be detected quantitatively by UV-vis absorption
spectroscopy.
Immobilization of the phosphotriesterase through physical adsorption on trityl agarose
has been reported^l The resulting immobilized enzyme exhibited 40% of the activity of
the soluble enzyme in degrading paraoxon. However, this immobilization method was
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complicated by the fact that paraoxon (and other substrates) showed some affinity to the
trityl agarose matrix. In order to suppress adsorption of paraoxon, addition of 10%
methanol was required. In an earlier report bacterial cell lysates containing
phosphotriesterase were covalently bound to controlled porous glass (CPG) and silica
(CPS)^^; 3-41% of relative activity were retained, depending on the level of protein
loading. The maximal relative activity was achieved with only 7 units of enzyme bound
per gram of porous silica. Since the study was conducted with crude cell extracts,
quantitative kinetic measurements were not reported. Both of these systems have been
proposed as continuous flow devices for detoxification of organophosphates.
This chapter will present the synthesis, purification and immobilization of a
recombinant phosphotriesterase (PTE) which catalyzes rapid hydrolysis of
organophosphate pesticides such as paraoxon. The highly active recombinant enzyme
was easily purified, and a simple method for immobilization was used. We chose silica
as the solid support for immobilization because of its low cost, high mechanical strength,
good thermal stability, and resistance to organic solvents and microbial attack^^. In
addition, silica would not be expected to bind paraoxon and should therefore be free of
the complications encountered with trityl agarose. The recombinant phosphotriesterase
immobilized on silica has been shown to be highly active towards hydrolysis of paraoxon
and is expected to be potentially useful for rapid detoxification and detection of
organophosphorus pesticides.
3.2 Experimental Section
3.2.1 Materials
Paraoxon (diethyl-p-nitrophenyl phosphate), [3-cyclohexylamino]-l-propanesulfonic
acid (CAPS), 2-[N-cycIohexylamino]ethanesulfonic acid (CHES), [N-2-
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hydroxyethylpiperazinel-N-2-ethanesulfonic acid (HEPES) and (2-N-morpholino)-
ethanesulfonic acid (MES) were purchased from Sigma Chemical Company. All except
paraoxon were used as received. Paraoxon was purified according to a reported
procedure^l and was dissolved in H2O to give a solution of final concentration of 5 mM.
The vectors pET-3b and pET-14b were purchased from Novagen, restriction enzymes
BamH I, EcoR I, Pst I and Nde I were obtained from New England Biolabs. Ni-NTA
resin was purchased from Qiagen, Inc. Isopropyl-p-thiogalactoside (IPTG) was used as
received from Calbiochem. Centriprep 10 ultrafiltration units were obtained from Amicon
Division, W. R. Grace & Co. Non-porous silica microspheres were purchased from
Bangs Laboratories, Inc.
3.2.2 DNA Construction
Plasmid pJK33 (obtained from Professor Frank Raushel of Texas A&M University)
was digested with BamH I and EcoR I, and the 1014 bp subcloned opd gene^^ encoding
the phosphotriesterase was isolated by agarose gel electrophoresis. A 21 bp linker
prepared from pUC18 by BamHI-EcoRI digestion was ligated with the opd gene to yield
a fragment designated opdl (Figure 3.1). pET-3b was linearized by digestion with
BamH I and purified by electrophoresis on a 1% agarose gel. The opdl fragment was
combined with the linear pET-3b fragment and the resulting population of recombinant
plasmids were used to transform bacterial strain HBIOI.
Colonies were selected and screened for insertion and orientation by digestion with
BamH I (supposed to yield fragments of 1035 bp and 4639 bp) and EcoR I (supposed to
yield fragments of 1524 and 4150 bp). The resulting recombinant plasmid (designated
pOL-1) was digested with Nde I and Pst I and the 2334 bp fragment containing the opdl
and T7 phage leader sequences was isolated by electrophoresis on a 1% agarose gel.
pET-14b was digested with Nde I and Pst I and the 3399 bp fragment ligated to the 2334
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bp fragment prepared as just described. The ligation mixture was used to transform E.
coli strain BL21(DE3)pLysS. Transformants were selected and plasmid DNA was
verified by digestion with Ava I (which yields fragments of 486, 1254 and 3993 bp).
The resulting expression plasmid (designated pOL-2) was subjected to partial digestion
with BamH I and treated with DNA polymerase to destroy the BamH I site at the 3' end
oiopd. The final recombinant plasmid (pOL-3) encodes 40 additional amino acids (for
the His-tag and T7 tag fused at the N-terminal Asn residue of the modified
phosphotriesterase reported by Mulbry and coworkers which involves deletion of the 33
N-terminal amino acids and replacement by the first 5 lac Z residues (Met-Ile-Thr-Asn-
Ser-) followed by the residues Gly34 of the native enzyme^ ^.
3.2.3 Expression and Purification of Recombinant Phosphotriesterase
Cells containing the recombinant plasmid were grown in 2 liters of rich tryptone-
phosphate medium^^ supplemented with 0.5 mM C0CI2 at 37 °C until ODcoo reached
0.8-1.0. Protein expression was iniuated with the addition of IPTG to a final
concentration of 0.4 mM. The growth temperature was kept at 30 °C. After 4 hours, the
culture reached OD600 ca. 1.5, corresponding to 4-5 g of cells (wet cell weight) per liter
of culture. Cells were harvested by centrifugation at 5,000 x g for 10 min at 4 'C. Cell
pellets were resuspended in 40 ml of ice-cold sonication buffer (50 mM sodium
phosphate buffer pH 8.0, 300 mM NaCl, 0.1 mM C0CI2 and 0.1% Triton X-100) and
stored at -80°C overnight.
The frozen bacterial cells were thawed at 37 °C for 90 min after addition of DNase
and RNase to a final concentration of 10 |ig/ml each. If cells didn't appear to be lysed
completely—if the solution was not viscous—cell mixtures were then sonicated on ice in
5 second pulses for 10 min. The following steps were performed at 4 °C. Clear cell
lysate was obtained after centrifugation at 12,000 x g for 30 min. Saturated (NH)4S04
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was added to the lysate dropwise to reach a final concentration of 50%. The mixture was
stirred for 60 min. The solution was centrifuged at 12,000 x g for 20 min, and the
precipitate was redissolved in 20 ml of sonication buffer.
The protein solution was added to 8 ml Ni-NTA agarose resin, preequilibrated with
sonication buffer. The mixture was stirred gently for 2 hours. The resin was collected
by centrifugation at 5,000 x g for 5 min and packed into a polypropylene column (1.6 cm
i.d.). The column was washed with sonication buffer until no significant decrease in
OD280 could be detected in the eluent (approximately 100 ml). The resin was then washed
with 80-100 ml wash buffer (50 mM sodium phosphate buffer, 300 mM NaCl, 0.1 mM
C0CI2, 10% glycerol, pH 6.0). Further washing was conducted with Tris buffer, pH
7.9, containing low concentrations of imidazole: 50 ml MCAC-0 buffer (20 mM Tris Cl,
pH 7.9, 500 mM NaCl, 0.1 mM C0CI2), 50 ml MCAC-5 buffer (MCAC-0 buffer, 5 mM
imidazole), 50 ml MCAC-20 buffer (MCAC-0 buffer, 20 mM imidazole) and 10 ml of
MCAC-60 (MCAC-0 buffer, 60 mM imidazole).
The target protein was eluted with 4 x 3 ml MCAC-200 buffer (most target protein
eluted in the 3rd fraction). The eluent was immediately subjected to buffer exchange into
HEPES buffer (50 mM HEPES, pH 8.5, 10% glycerol and 0.1 mM C0CI2) using a Bio-
Rad Econo-Pac lODG prepacked column (a polyaerylamide-based size exclusion
column). The enzyme solution was further concentrated to 0.6 mg/ml by ultrafiltration
using a Centriprep 10 column. Proteins were analyzed by electrophoresis on 12% SDS-
polyacrylamide gel. Quantitative measurements of protein concentration were made by
the Bradford method with bovine serum albumin as standard^.
3.2.4 Immobilization Procedure
Non-porous silica microspheres (0.8 ^m diameter) were dried at room temperature
under vacuum before use. Recombinant phosphotriesterase solution (0.6 mg/ml in 50
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mM HEPES buffer, pH 8.5) was added in a ratio of 6 mg enzyme/g beads. The
suspension was mixed well with repeat peppeting and incubated at 4 °C overnight. The
beads were washed extensively with 50 mM HEPES buffer. pM 8.5, until no activity was
detected in the wash, and then resuspendcd in IlEPES buffer. The extent of
immobilization was determined from the difference between the amount of enzyme added
to the suspension and the amount present in the wash solution. Protein adsorption was
also determined from the difference in the enzymatic activities of the incubation and wash
solutions.
3.2.5 Enzyme Activity Measurements
For the soluble recombinant phosphotriestcrase, enzymatic activity was measured
using paraoxon as the substrate in 150 mM CUES buffer at pll 9.0. The reaction was
monitored through the absorbance of the hydrolysis product /7-nitrophenolate (X,max 400
nm, e=17,000 cm ')'^. The UV-vis absorption spectra were collected on a Hitachi
Model 2600 spectrophotometer. One unit of activity is defined as the amount of enzyme
that hydrolyzes 1 ^imol of paraoxon per minute. For the immobilized phosphotriestcrase,
enzyme-treated beads were suspended in 150 mM CHES buffer, pH 9.0. Enzyme
activity was monitored through the absorbance at 400 nm upon addition of substrate
paraoxon.
The initial reaction velocity was measured for paraoxon concentrations ranging from
0.025 to 1.5 mM. The kinetic constants were detemiined from the Michaelis-Menten
equation, V = VmS / (Km + S), where V is the initial velocity, Vm the maximal velocity,
S the substrate concentration and Km the Michaelis constant. The kinetic constants were
determined in at least three independent measurements, each using twelve paraoxon
concentrations.
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The rate of enzymatic hydrolysis of paraoxon (1 mM) was determined for both the
soluble and immobilized forms of the phosphotriesterase at pH values from 4 to 1 1. The
pH value was adjusted with the following buffers (100 mM sodium acetate buffer, pH
4.0, pH 5.0; 100 mM MES, pH 6.0; 100 mM MOPS, pH 7.0; 100 mM HEPES, pH 8.0;
100 mM CHES, pH 9.0 and 100 mM CAPS, pH 10.0, pH 11.0)
3.2.6 Stability Study
The stability of the immobilized and soluble forms of the phosphotriesterase were
examined via activity measurements using 1 mM paraoxon in 150 mM CHES buffer, pH
9.0. Thermal stability was evaluated by incubating the enzyme at 55 "C for 60 minutes in
150 mM CHES buffer, pH 9.0. Aliquots of enzyme solution or suspension were
removed at 10 minute intervals and activity was determined as described above. Stability
upon prolonged storage at 4 °C was also determined using 0.3 |J.g/ml of enzyme, 0.5 mM
paraoxon in 150 mM CHES buffer, pH 9.0. At intervals of five to ten days aliquots were
collected, diluted with 50 mM HEPES buffer, pH 8.5, and assayed for enzymatic activity
as described above.
3.2.7 Activity Upon Repeated Use
An aliquot of the immobilized recombinant phosphotriesterase on glass beads (75 ^im
diameter) was resuspended in 150 mM CHES buffer, pH 9.0, in the filter of a Spin-X
(Fisher) centrifuge unit (0.2 ^im). Paraoxon (2.0 mM) was added to start the hydrolysis
reaction, and the supernatant was isolated after 5 seconds by centrifugation. The
absorbance of the supernatant was measured at 400 nm. The beads isolated in the upper
filter were resuspended and subjected to the same procedure through 10 cycles.
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3.3 Results and Discussion
3.3.1 Expression and Purification of Recombinant Phosphotriesterase
A gene encoding a recombinant phosphotriesterase containing six consecutive
histidine residues at the N-terminus was constructed and expressed in Escherichia coli
under control of a T7 phage promoter^"^. Expression was visualized in whole cell lysates
by both Coomassie Blue staining and western blotting methods. The target protein
appeared in the lysate after one hour of induction and continued to accumulate for 4
hours, as indicated by growth of a strong new protein band at ca. 40 kDa on SDS-PAGE
(Figure 3.2a). A T7 phage derived sequence near the N-terminus allowed easy detection
of the target protein by western blotting; observation of a single band on the blot,
indicating lack of C-terminal protein degradation (Figure 3.2b). Further analysis showed
that the recombinant enzyme partitioned between soluble and insoluble (inclusion body)
fractions in the expression strain. Cells were grown at 30 "C in rich tryptone phosphate
medium to reduce inclusion body formation'^-^, and Co^"*" (0.5 mM) was included in the
growth medium to improve the enzymatic activity of the target protein^^
The recombinant enzyme was purified from the soluble fraction of the whole cell
lysate by ammonium sulfate precipitation followed by chromatography on Ni-NTA
agarose^^ (Table 3.1). The homogeneity of the protein was verified by SDS-PAGE
(Figure 3.3) and amino acid analysis (Table 3.2). The purified recombinant
phosphotriesterase (PTE) exhibited a specific activity of 5630 units/mg.
Phosphotriesterase from Pseudomonas diminuta has been expressed in E. coli , with
deletion of the 33 N-terminal amino acids and fusion the fu-st 5 lac Z residues (Met-Ile-
Thr-Asn-Ser-) at the N-terminal glycine of the truncated enzyme'l. The authors reported
a yield of 298 mg of protein from 160 g of bacterial cells and a specific activity of 8020
units/mg using 1 mM Co2+ in the growth medium. In our expression system, however,
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the concentration of cobalt ion was limited to 0.5 mM; 1 mM or 0.75 mM Co2+ was too
toxic for BL21(DE3) pLysS cells to grow efficiently and the optical density did not
exceed 0.8. The decreased PTE activity of our system might be a result of the lower
concentration of Co2+ in the growth medium. It could also be attributed to the additional
40 amino acid residues at N-terminus of the reported enzyme; the recombinant PTE has
molar mass of 40,247 Da compared to 34,524 Da expressed in E.coli previously. If
normalizing with molecular weight, the activity of the recombinant PTE is 82% of that of
the enzyme previously reported. Nevertheless, the recombinant phosphotriesterase
remained highly enzymatically active, with a specific activity of 5630 units/mg toward
hydrolysis of paraoxon.
3.3.2 Immobilization of PTE on Silica Beads
The purified recombinant phosphotriesterase was immobilized on silica through
physical adsorption. Non-porous silica beads were used as solid support to reduce the
mass transfer effect. Microspheres of 0.8 |J.m in diameter were chosen to provide
sufficient surface area for protein adsorption. The enzyme was adsorbed quantitatively to
the microspheres yielding 34 units of enzyme per milligram of beads. The amount of
protein adsorbed on the silica, 6 mg enzyme/g beads, allows approximately monolayer
coverage estimated from the dimension of the crystal structure of the holoenzyme (50 A in
diameter per subunit)'^.
The immobilized recombinant phosphotriesterase has a specific activity of 5200
units/mg, which is comparable to the value obtained for the soluble enzyme when
paraoxon is used as the substrate (Table 3.3). This is the highest activity reported to date
for an immobilized form of the phosphotriesterase. Immobilization of the
phosphotriesterase has been reported previously by Caldwell and Raushel'^, who used
trityl agarose to bind the enzyme through hydrophobic interaction. The maximal activity
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of their system was 40% of that of the soluble enzymes, which they purified to a specifn
activity of 3200 units/mg^l Moreover, the assay used for evaluation of the immobilized
enzyme was complicated by adsorption of the substrate on the hydrophobic support, and
addition of 10% methanol was required to reduce the affinity of substrate for the agarose
matrix. In a control experiment, the immobilized phosphotriesterase on silica showed no
significant change in catalytic activity with inclusion of 10% methanol in the reaction
buffer, indicating that silica as a matrix has little or no affinity for the reaction substrate or
products. Methanol is therefore not required for activity measurement in the system
reported here.
The molecular interactions involved in adsorption of the phosphotriesterase on silica
are likely to be complex. Electrostatic interactions between amino groups of the enzyme
(NHs"'') and dissociated silanol (SiO') groups of silica seem to be involved. The
recombinant phosphotriesterase was immobilized up to 98% on silica when incubated in
buffers with pH from 5 to 1 1 (Table 3.4), displaying varied relative activity (40% to
100%) compared to the soluble form. However, when incubated at buffers with pH
value of 13 and greater, only about 5% of the enzyme was adsorbed.
Analysis of the crystal structure of the phosphotriesterase reveals 10-16 basic groups
(lysine and arginine) on the surface of the enzyme^ ^. The isoelectric point of the
recombinant phosphotriesterase is calculated to be 8.7. When incubated in a buffer at pH
13, which is above pKa values of the lysine and arginine, the enzyme should have few
positive charges on the surface and therefore little protein adsorption occurs under such
conditions. Ionic interactions are found in other immobilized proteins on glass. It has
been reported that the rate of initial protein adsorption depends on surface charge of the
protein. The higher the isoelectric point of the protein, the higher the adsorption rate^^.
On the other hand, ionic interaction of amino and silicate groups seems not to be the only
force for recombinant enzyme adsorption. Hydrogen bonding between silanol and the
enzyme is also likely involved. High ionic strength buffer solutions (NaCl up to 2 M)
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were not able to elute the phosphotriesterase from silica in detectable quantity. The
additional six N-terminal histidine residues on the recombinant phosphotriesterase may
also play a significant role in the hydrogen bonding, especially considering that they are
likely to be accessible on the outer surface of the protein compared to the seven other
histidines in the native enzyme^^ Hydrophobic interactions seem to be less significant,
as protein adsorption was not affected with addition of up to 2% of the nonionic
surfactant Triton X-100 in the incubation buffer. No significant desorption of the enzyme
was observed when up to 4% of the surfactants SDS or Triton X-100 were included in
the elution buffer.
The phosphotriesterase has been shown to be a membrane-associated enzyme in the
host microorganism Flavobacterium sp^^. The enzyme is expressed as a precursor with
365 amino acid residues and is processed through a post-translational modification in
which 29 amino acids at the N-terminus are removed to give the mature form^^. For
cloning in E. coli, Mulbry and coworkers deleted the leader sequence in order to yield the
soluble and enzymatically active protein The recombinant phosphotriesterase
immobilized on silica might provide information on the native membrane-bound enzyme.
The immobilized enzyme exhibits activity similar to that of soluble form. It suggests that
the orientation of the enzyme on the silica surface that maintains maximal preservation of
the active site. The immobilized phosphotriesterase on silica might provide some insight
on the activity of the enzyme in vivo.
3.3.3 Kinetic Study
Kinetic study of the soluble recombinant phosphotriesterase shows that the enzyme
follows Michaelis-Menten kinetics, giving a linear correlation on Lineweaver-Burk plots
(Figure 3.4). The recombinant enzyme catalyzed hydrolysis of paraoxon resulting in a
catalytic rate constant (kcaO of 3880 ± 310 s ' (Table 3.3). The additional His-tag
didn't
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significantly affect the enzymatic activity; the recombinant phosphotriesterase activity is
comparable to that of the bacterial phosphotriesterase from Pseudomonas diminuta^^.
The immobilized phosphotriesterase exhibits kinetics similar to those of the soluble
form, as shown in the linear Lineweaver-Burk plots (Figure 3.4) over a wide range of
paraoxon concentrations (0.025 mM-1 mM). The kinetic constants of the immobilized
phosphotriesterase were determined (Table 3.3). The kcai value of the immobilized
phosphotriesterase is 3490 ± 500 s ^ comparable to that of the soluble enzyme. The Km
value of the immobilized phosphotriesterase, however, is 3-4 times higher than that of the
soluble enzyme. A similar increase in Km was reported for the phosphotriesterase
immobilized on trityl agarose^ ^. The higher Km value might be due to external and
internal diffusion effects upon immobilization^^. The mass transfer effect of the substrate
to the immobilized phosphotriesterase could be very significant, considering the rate
determining step for catalytic hydrolysis of paraoxon in solution was the diffusion
limit29.
The activity of the immobilized phosphotriesterase was determined in the pH range
from 4 to 11, as shown in Figure 3.5. The immobilized phosphotriesterase has a
narrower optimal pH range than the soluble enzyme, giving maximal activity between pH
8 and 9. The pH profile of the immobilized phosphotriesterase is comparable with that of
the soluble enzyme from pH 4 to 9. In the higher pH region, the immobilized enzyme
showed lower relative activity than the soluble system, possibly due to desorption of the
enzyme from silica.
3.3.4 Stability of the Immobilized Phosphotriesterase
One of the most frequently cited advantages of immobilized enzymes is improved
stability^^. It has been suggested that through confinement on a solid support, enzymes
should be more likely to resist conformational changes and thus exhibit
higher stability
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than soluble enzymes. In our studies, enzymatic activity was tested at elevated
temperature, after prolonged storage time and after dilution with buffer. The stability of
the immobilized phosphotriesterase under such conditions was compared with that of the
soluble enzyme.
3.3.4.1 Thermal stability
When incubated at 55 °C, the soluble enzyme showed a distinct loss of activity within
30 minutes and retained only 20% of its original activity after 60 minutes (Figure 3.6).
On the other hand, the activity of the immobilized phosphotriesterase remained constant
over a period of 60 minutes at 55 °C. This result indicated that the immobilized
phosphotriesterase is more stable than the soluble enzyme at elevated temperature.
3.3.4.2 Storage Stability •
While stored at 4 °C, both the soluble and the immobilized forms of the
phosphotriesterase showed good stability for up to 20 days. Less than 5% of initial
activity was lost during this time. After storage for 32 days at 4 °C, the activity of the
soluble enzyme was reduced to 65% of its initial value, while the immobilized enzyme
retained 84% of its initial activity (Figure 3.7). The activities of both the soluble and the
immobilized enzyme remained approximately constant thereafter for up to 8 months.
From these measurements the immobilized enzyme exhibited more stability during
prolonged storage at 4 °C than the soluble protein.
3.3.4.3 Stability Upon Dilution
The soluble phosphotriesterase showed significant loss of activity upon dilution.
When the soluble enzyme was diluted 5-fold from an initial concentration of 0.6 mg/ml
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with HEPES buffer, only 25% of the expected activity was observed (Figure 3.8).
Further dilution resulted in loss of activity to a level of 10 % of the original value. The
phosphotriesterase was determined to be a homodimer from the X-ray study of its crystal
structure'5. Dilution of the enzyme in solution may cause dissociation of the dimer and
result in formation of enzymatically inactive monomer. Another possible reason for such
a decrease could be the partial unfolding of the enzyme upon dilution. On the other hand,
the immobilized phosphotriesterase was insensitive to dilution. The activity of the
immobilized enzyme remained constant up to 20 fold dilution. Such a result indicated that
the recombinant phosphotriesterase gained dimensional stability upon immobilization and
was much easier to handle in a variety of concentrations compared with the soluble form.
3.3.5 Activity of Immobilized Phosphotriesterase Upon Repeated Use
One of the advantages of an immobilized enzyme is its ease of separation from the
reaction products and compatibility with continuous processes. It is therefore important
to determine the activity of the immobilized phosphotriesterase in multiple cycles of use.
In addition, since the recombinant enzyme is immobilized on a surface through physical
adsorption instead of chemical bonding, it is necessary to verify whether the measured
activity is really from the immobilized enzyme or from the desorbed soluble enzyme
during reaction. The activity of the immobilized phosphotriesterase was measured
sequentially through 10 cycles of use (see Figure 3.9). The relative activity was
depressed to approximately 80% of its initial value during the first three cycles; thereafter
the activity remained constant. The initial decrease in activity may have been a result of
enzyme desorption, as increases of absorbance at 4(X) nm over time were observed in the
first few eluents. However, the immobilized recombinant phosphotriesterase preserved a
majority of the enzymatic activity in repetitive uses. This suggests that the immobilized
enzyme is a good candidate for used in continuous devices.
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3.4 Conclusions
A recombinant bacterial phosphotriesterase (PTE) bearing an N-terminal hexahistidine
sequence was constructed through genetic engineering and expressed in E. coli under
control of a T7 phage promoter. The hexahistidine tag allows purification of the
recombinant enzyme by metal chelate affinity chromatography. The recombinant enzyme
followed Michaelis-Menten kinetics with a catalytic rate constant of 3880 ±310 s ' for
hydrolysis of paraoxon. The activity of recombinant PTE was shown to be 82% of that
reported for the bacterial phosphotriesterase, as calculated by normalization of the
molecular weights of the two proteins.
.
The recombinant phosphotriesterase was immobilized on non-porous silica
microspheres by simple physical adsorption. The optimal amount of enzyme adsorbed in
this system was 34 units of enzyme activity per mg of support, yielding near monolayer
coverage. The protein-surface interaction was attributed to a combination of ionic and
hydrogen bonding. Like the soluble form of the enzyme, the immobilized
phosphotriesterase followed Michaelis-Menten kinetics, with a catalytic rate constant of
3490 ± 500 s-'. The Michaelis constant Km was 3-4 times higher than that of the soluble
enzyme, possibly due to the external and internal diffusion effects upon immobilization.
The immobilized enzyme has been shown to exhibit higher stability towards heat, storage
and sample handling compare to the soluble fomi of the protein. It remains highly active
upon repeated use.
The immobilized recombinant phosphotriesterase, by virtue of its ease of preparation,
high catalytic activity and broad substrate range, offers good potential for the
development of biosensors and column reactors for rapid detection and detoxification of
organophosphorus pesticides and nerve agents.
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Table 3.1 Purification of recombinant phospholrieslcrase
Fraction Total protein Total activity Specific Yield Purification
activity
units X I (y^ units/m}i % fold
Cell lysate"
Ammonium
sulfate ppt
Ni-NTA
576
248
2.3
4.33
4.56
1.30
74.8
184
5630
100
105
30.0
1
2.4
75
a Isolated from 2 liters of culture grown to ODf^)o = 1.59 (4.5 g/L wet cell weight).
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Table 3.2 Amino acid composition of the recombinant phosphotriesterase^
/\I111I1U <ICIU rredictcci'^ Analysis^
Ala 10.7 9.9
Uiy o o 10.2
Cjlx(Ulu+01n) 7.5 7.3
Asx(AspH-Asn) 7.3 6.3
r ne /I4.U 3.9
I Ho ^ /I3.4
He 6.7 5.5
Lys 2.1 1.9
Leu 9.1 8.5
Met 2.4 2.9
Pro 4.6 5.8
Arg 7.8 8.4
Ser 9.1 10.8
Cys 0.5 <0.03
Thr 6.7 6.1
Val 6.4 5.9
Tyr 1.3 1.2
Trp 1.1
^Determined in niol%
^'Deduced from the DNA sequence encoding the proceeding protein
^Values were obtained by calculations based on molecular weight of 40247,
derived from amino acid sequence.
^ND: not determined
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Table 3.3 Kinetic constants of soluble and immobilized recombinant phosphotriesterase^
Specific activity
(units/mg)
Km (m) kcat (sec -i) kcat / Km
(10 7 M-^ s-1)
Soluble 5630 150 ±50 3880 ±310 2.6
Immobilized 5200 480 ± 90 3490 ± 500 0.7
" The purified phosphotriesterase has been reported^^ to exhibit specific activities of
3200-8020 units/mg, Km 130 and kcat 4870 sec'l.
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Table 3.4 Immobilization of phosphotriesterase on silica at different pH values'*
pH 5.3 6.8 8.5 11 >13
Enzyme
adsorbedb(%) 100 99.9 98 5.3
Relative activity^
64 39 92 104 4
(%)
^Phosphotriesterase was incubated with silica microspheres at a concentration of 6 mg
protein / g silica. Enzymatic activity was determined in a 150 mM CHES buffer, pH 9.0,
^Enzyme adsorption was determined from the enzymatic activity difference between the
incubated beads and the wash solution.
^Relative activity is the ratio of reaction rate of the immobilized enzyme to that of the same
amount of soluble enzyme for hydrolysis of 1 mM paraoxon.
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EU opd
Cut E, B
1014 bp
1. Linker
2. T4 Ligase
3'
Linker;
5'
BamHI
gatccccgggtaccgagctcg
gggcccatggctcgagcttaa
EcoRI
Restriction Enzvmes:
E - EcoR I, B - BamH I
N-Ndel, P-PstI
B N
Cut N,P
T4 Ligase
Cut N
1. Partial digestion with BamHI
2. DNA polymerase
3. T4 ligase
(B) N
Figure 3.1 DNA Diagram of construction of recombinant phosphotriesterase
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Figure 3.2 SDS-PAGE analysis of expression of the recombinant phosphotriesterase in
E. coli strain BL21(DE3)pLysS. Shown as whole cell lysates at intervals
after IPTG induction, (a) Gel stained with Coomassie Blue, (b) Western blot
with monoclone T7 antibody. Lane 1, molecular weight markers (from top
to bottom, 97.4, 45 and 31 kDa); lanes 2 - 6: cell lysates at 0, 1, 2, 3 and 4
hours after induction, respectively.
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1 2 3 4 5
Figure 3.3 SDS-PAGE of purification of the recombinant phosphotriesterase. Lane 1,
molecular weight markers (from top to bottom, 97.4, 45 and 31 kDa); Lane
2: cell supernatant; lane 3: protein precipitated from 50% ammonium sulfate;
lane 4: eluted fraction from Ni-NTA column with sonication buffer
containing 60 mM imidazole; lane 5 and 6: two fractions of eluent from
buffer containing 200 mM imidazole.
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Figure 3.4 Lineweaver-Burk plots for the soluble (0) and immobilized (•) recombinant
phosphotriesterase.
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Figure 3.5 pH profiles of the soluble (0) and immobilized (•) recombinant
phosphotriesterase in the hydrolysis of paraoxon (1 mM).
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Figure 3.6 Thermal stability of the soluble (0) and immobilized (•) recombinant
phosphotriesterase at 55
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Figure 3.7 Storage stability at 4 °C for soluble (0) and immobilized (•) recombinant
phosphotriesterase.
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Figure 3.8 Activity of soluble (0) and immobilized (•) recombinant phosphotriesterase
for hydrolyzing paraoxon when diluted with 50 mM HEPES buffer, pH 8.5.
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Figure 3.9 Activity of immobilized phosphotriesterase upon repeated use in the
hydrolysis of paraoxon.
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CHAPTER 4
DETERMINATION OF ORGANOPHOSPHATE PESTICIDES BY CONTINUOUS
FLOW BIOSENSORS
4.1 Introduction
Organophosphate pesticides have been widely used in developed countries because of
their high effectiveness. However, their use also causes environmental concerns due to
their acute toxicity as cholinesterase inhibitors^ Organophosphorus pesticides are highly
toxic by all routes of exposure including ingestion, dermal absorption and inhalation^.
Severe poisoning can affect the central nervous system, producing lack of coordination,
slurred speech, loss of reflexes, weakness and fatigue. Repeated and prolonged
exposure to organophosphates may result in symptoms such as impaired memory,
disorientation, severe depression and speech difficulties. Contamination by residual
organophosphate pesticides has been found widely in the environment including soil,
ground water and vegetation-^, and rapid detection methods are therefore of great
interests. Currentiy, most pesticide residue determination has been performed by gas
chromatography with element-selective detectors, with confirmation of results using an
ancillary method such as mass spectroscopy"*. Residue concentrations can be determined
with such methods at low parts per million (ppm) to parts per billion (ppb) levels;
however, the required instrumentation is expensive and the analysis is time-consuming.
Flow injection analysis (FIA)^ is a continuous flow method that is fast, accurate,
versatile and simple to operate. Over the past fifteen years, FIA techniques for automatic
on-line sample analysis and monitoring have drawn widespread research interest^. Flow
injection analysis based on biological systems such as enzymes or antibodies provide
advantages of specificity and sensitivity, and have been a very active field of research''.
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Only a few biologically based systems have been developed for organophosphate
pesticide detection, as few enzymes or antibodies recognize the synthetic
organophosphates. Inhibition of acetylcholinesterase has been used with potentiometric
or amperometric detection for organophosphate pesticide determination via decrease of
enzymatic activity ^, with detection limits as low as 30 ng/ml
. This measurement has
several drawbacks, including the use for two sample injections (inhibitor and substrate)
and the requirement for reactivation of the enzyme reactor.
The phosphotriesterase from Pseudomonas diminuta hydrolyzes a wide variety of
organophosphates including some of the most commonly used organophosphate
pesticides and deadly nerve agents^. Crystal structure analysis shows that the enzyme
consists of a homodimer of 39 kDa subunits^^. The enzyme is stable over broad range of
pH and temperature, and the catalytic mechanism has been studied extensively by Raushel
and coworkers'^' The natural substrates of the enzyme are not known. Paraoxon
(diethyl-/7-nitrophenyl phosphate), an active metabolite of parathion (a commonly used
organophosphate pesticide), is hydrolyzed by the phosphotriesterase at rate near the
diffusion limit'-^. Hydrolysis of paraoxon, as shown in the following reaction,
O O
EtO-P-0-HQ>—NO2 EtO-P-O" + "0-Q)-N02
OEt ^ OEt
produces a brightly colored phenolic product with an extinction coefficient of 17,000
M-^cm"^ at 400 nm^, which can be detected quantitatively by UV-vis spectrophotometry.
We reported recently a recombinant phosphotriesterase (PTE) that was expressed in
Escherichia coli and purified by immobilized metal affinity chromatography'"^. The
recombinant enzyme catalyzed hydrolysis of paraoxon with a reaction rate similar to that
of the native enzyme from Pseudomonas diminuta, and could be immobilized on non-
porous silica microspheres through simple physical adsorption. The immobilized
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phosphotriesterase showed specific activity comparable to that of the soluble enzyme, and
followed the same Michaelis-Menten kinetics with a turnover number of 3490 ± 500 s'l.
It exhibited higher stability towards heat, storage and sample handling compare to the
soluble form of the protein. The immobilized phosphotriesterase has many advantages,
including its direct determination of pesticides, ease of preparation, exceptionally high
activity and broad substrate range. Here we wish to report, for the first time, application
of the immobilized phosphotriesterase to the construction of a continuous-flow injection
system for the sensitive, selective and rapid detection of paraoxon.
4.2 Experimental Section
4.2.1 Equipment
A Perkin-Elmer Lambda 3 UV-vis spectrophotometer was furnished with a 1 cm (18
(ll) path length flow cell (Pye Unicam) and equipped with a Hewlett-Packard 3394A
integrator. An Ismater Ms-Reglo variable speed peristaltic pump (Ismater SA) was used
to control flow rate. A six-port Teflon rotary valve (Omnifit, New York, NY) was used
as an injector. All unions and end fittings were made from poly(ether ether ketone)
(PEEK) (Upchurch, Oak Harbor, WA). Tubing was 0.8 mm i.d. Teflon from Omnifit.
4.2 2 Reagents and Solutions
[N-2-hydroxylethylpiperazinel-N-2-ethanesulfonic acid (HEPES), 2-[N-
cyclohexylaminojethanesulfonic acid (CHES), and paraoxon were purchased from Sigma
Chemical Company. HEPES buffer contained 50 mM HEPES, pH 8.5, 2% glycerol,
and 0.1 mM C0CI2. Paraoxon was purified by dissolution in dichloromethane following
by extraction with 10 mM CHES buffer, pH 9.0 according to a reported procedure^
^
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The purified paraoxon was dissolved in water in a final concentration of 0.5 mM and
stored at 4 'C. Recombinant phosphotriesterase was expressed in £. coli and purified by
immobilized metal affinity chromatography'! The purified enzyme was adjusted to a
final concentration of 0.6 g/ml in 50 mM HEPES buffer, pH 8.5 and stored frozen at -80
"C in 200 ^il aliquots. The specific activity of the enzyme was determined to be 5630
units/mg, where one unit of activity is defined as the amount of enzyme that hydrolyzes 1
|imol of paraoxon per minute at saturating concentration of the substrate.
4.2.3 Enzyme Immobilization
Glass beads (75 |im diameter) were dried at room temperature under vacuum before
use. The recombinant phosphotriesterase solution was added in a ratio of 85 units of
activity per gram of beads. The suspension was mixed well and incubated at 4 °C
overnight. The beads were washed extensively with 50 mM HEPES buffer, pH 8.5,
until no activity was detected in the wash. The extent of immobilization was determined
from the difference between the activity incubated with the beads and that in the wash.
The immobilized enzyme was packed into polypropylene tubes of dimension 2 mm (i.d.)
X 2 cm for use in FIA.
4.2.4 Manifold and Procedure
The flow injection system is shown schematically in Figure 4.1. The carrier solution
(HEPES buffer) was pumped by a peristaltic pump at steady flow rate in the range of 0.2-
4 ml/min. An aliquot of paraoxon solution in HEPES buffer was injected upstream of the
immobilized phosphotriesterase column where the substrate was hydrolyzed to p-
nitrophenolate. The hydrolysis products were passed through the flow cell and the
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absorbance was read continuously at 400 nm. Peak height and peak area were
determined by the calibrator and correlated with the paraoxon concentration in the sample.
4.2.5 Soil Sample Extraction
An Environmental Protection Agency (EPA) standard procedure was used for soil
sample extraction. Soil samples were obtained from a local farm and dried in a vacuum
oven at 105 'C. The dried soil was sieved through a 2 mm mesh sieve to obtain a rock-
free soil sample. Two portions of approximately 50 g of soil were weighted and spiked
with 0.5 ml of paraoxon stock solution (1.25 mg/ml). Acetone (40 ml) was added to
each sample and the mixture was shaken vigorously for 20 minutes. Ilexane (80 ml) was
added and the samples were shaken for an additional 10 minutes. The samples were
allowed to settle and the solvent was decanted into a 1 liter separatory funnel. The
extraction was repeated with 20 ml acetone (20 minutes), followed by 80 ml of hexane
extraction (10 minutes). The extracts were combined and back-extracted with distilled
deionized water (5(X) ml) with gentle mixing. The organic layer was collected, combined
with an additional 25 ml of hexane extract of the aqueous .solution, and then passed
through a column of sodium sulfate. The organic extract was concentrated by rotary
evaporation under reduced pressure and dissolved in acetone (10 ml). The sample was
diluted 20-fold with I lEPES buffer and analyzed by FIA.
4.3 Results and Discussion
Immobilization of the recombinant phosphotriesterase on glass beads yielded near
monolayer coverage, as estimated from the dimensions of the enzyme'^. The column
reactor used in the flow injection device incorporated 17 units of phosphotriesterase
activity. The carrier buffer was 50 mM IlEPES, pi I 8.5, in which the immobilized
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enzyme has been shown to maintain optimal activity for periods in excess of 6 months^l
Spectrophotometric determination of paraoxon was achieved by the measurement of the
absorbance peak height and peak area of the hydrolyzed product p-nitrophenolic ion at
400 nm. As shown in figure 4.2, triplicate injection of paraoxon samples ranging from
12.5 [Lg/m\ to 75 ng/ml results in incremental increases of the recorded peak area with
increasing paraoxon concentration. The measurement showed good reproducibility
(within 5% standard deviations) at each concentration.
4.3.1 Improvements of Variables
The following variables affecting the performance of the system are studied for
determination of paraoxon concentrations in aqueous solution.
4.3.1.1 Variation of Flow Rate
The flow rate has a dramatic influence on the performance of the system. Flow rates
ranging from 0.32 to 3.8 ml/min were studied at various concentrations of paraoxon
(Figure 4.3). It is shown that absorbance peak area increases with decreased flow rate.
Lower flow rate results in longer residence times of the analyte in the enzyme reactor and
therefore higher extents of hydrolysis; a further increase in area at low flow rate arises
from the longer residence time of the product chromophore in the detector cell. The area
of the absorbance peak was shown to increase 3-4 times when the flow rate decreased
from 2 ml/min to 0.5 ml/min. The trend for the absorbance peak height with flow rate is
a bit more complicated (Figure 4.4). When paraoxon was injected at 25 )ig/ml, at flow
rates ranging from 0.32 to 1.7 ml/min, the peak height increased with lower flow rate
which could be attributed to formation of more hydrolysis product . The broader peaks at
lower flow rate result from the longer residence time of the chromophore in the flow cell.
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It is observed that the peak heights at 0.32 and 0.48 ml/min didn't seem to be
significantly different, suggesting complete hydrolysis of paraoxon. At high flow rate
range (1.7-3.2 ml/min), however, the absorbance peak height decreases with decreased
flow rate. The absorbance peak height reflects the concentration of p-nitrophenolate in
the flow cell, while the peak area integrates the absorbance with time in the flow cell. In
the high flow rate range, lower flow rate could result in dilution of the chromophore in
the detector cell; and there are not significant increases in extent of hydrolysis to offset the
dilution. Furthermore, decreases in flow rate result in loss of sampling frequency. A
flow rate of 0.5 ml/min was selected for determination of low concentrations of paraoxon
at a sample rate of at least 20 per hour.
4.3.1.2 Variation of Injection Volume
The volume of sample injection is another important factor that affects FIA
performance. Larger injection volumes give more sensitivity as more sample is available
for hydrolysis. On the other hand, increasing injection volume gives broader peaks that
could affect detection accuracy and decrease the frequency of sample testing. Injection
volumes of 50 jil to 500 \i\ were tested. As shown in figure 4.5, the area of under the
absorbance increases six-fold when injection volume changes from 50 |il to 500 )il.
4.3. 1 .3 Variation of Manifold Length
The overall manifold length was varied from 40 cm to 100 cm. The manifold length
is important for dispersion of the sample and sampling frequency. We found an overall
increase of four fold in the detection signal with a 2.5 fold reduction in manifold length
from 100 cm to 40 cm. A manifold length of 40 cm was selected for measurements.
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4.3.2 Paraoxon Analysis
A calibration curve was prepared by using selected values of the variables stated in the
previous section. We used both 50 [i\ and 500 |il injection volumes and compared
detection limits achieved and the relative standard deviations of the measurement.
Solutions of paraoxon at concentrations between 25 ng/ml and 25000 ng/ml were injected
in triplicate. As summarized in Table 1, when 50 |il sample was injected, a linear
correlation was obtained between 125 ng/ml and 25000 ng/ml paraoxon, with an excellent
regression coefficient (Figure 4.6). The detection limit was 25 ng/ml. The sampling
frequency under optimal conditions was 32 per hour. When the injection volume was
increased 500 }il, the linear determination range was extended from 25 ng/ml to 25000
ng/ml paraoxon and a detection limit of 5 ng/ml was achieved. On the other hand,
sampling frequency is decreased to 24 per hour.
A paraoxon sample was obtained from the EPA certified Massachusetts Pesticide
Analysis Laboratory at the University of Massachusetts and the concentration was
determined by our flow injection technique. We obtained a value of 19.7 ± 1.2 |ig/ml,
while the pesticide laboratory using GC analysis with flame photometric detection,
reported 20.9 ± 0.8 |ig/ml. The two results are in good agreement and validate the
application of flow injection analysis for determination of paraoxon.
The immobilized phosphotriesterase reactor was stable with retention of more than
90% activity for one month under repeated use. Previous studies of the stability of the
immobilized phosphotriesterase have shown the enzyme to maintain 80% of its initial
activity for up to 8 months of storage at 4 °C.
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4.3.3 Determination of Paraoxon in Soil Samples
Soil samples were selected to study the validity of the proposed method in
determining organophosphate pesticide residues in environmental samples. A soil sample
(50 g) was spiked with 625 ^ig (12.5 ppm) of paraoxon and the pesticide was extracted
into 10 ml of acetone. Acetone solutions were diluted 20-fold with 50 mM HEPES
buffer, pH 8.5 for FIA analysis. The calibration curve was constructed from paraoxon
added to blank solutions prepared by the same extraction method without paraoxon
added. The FIA method gives 286 ±2\ig paraoxon, yielding 46% recovery of pesticide.
The sample was cross-checked by the Pesticide Laboratory using GC with flame
photometric detector. The amount of paraoxon determined by the GC method was 309
|J,g, yielding recovery of 49%. Although the extraction procedure needs to be improved
in order to get higher sample recovery, the pesticide determined by the proposed FIA
method is in good agreement with the EPA standard method. However, the result was
complicated by the high background of the blank soil samples. Since the extraction
procedure was a standard EPA method for GC analysis, further study is necessary to
develop a soil extraction method that is more suitable for the proposed FIA method. The
background of the soil blank could be reduced by cleaning up die extracted sample,
and/or by using a different solvent for extraction. Nevertheless, preliminary results from
soil samples demonstrated the applicability of the flow injection method using an
immobilized phosphotriesterase reactor for pesticide detection in environmental samples.
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4,4 Conclusions
For the first time, a direct photometric method using a flow injection biosensor is
proposed for the detection of organophosphate pesticides. The method is based on
hydrolysis of pesticide by a highly active immobilized enzyme reactor, yielding a
hydrolysis product which is quantitatively determined by electronic absorption
spectroscopy. The advantages of the proposed method are: (1) simplicity—the method
requires a single line manifold system, and the absorption measurement of the detected
signal is directly proportional to the sample concentration; (2) sensitivity—a detection
limit of 5 ng/ml was achieved by the proposed method, which is comparable with the
current standard GC method; (3) specificity—only substances that are substrates for the
phosphotriesterase can be detected. As the enzyme hydrolyzes a variety of
organophosphate pesticides, the proposed method is expected to determine other pesticide
substrates besides paraoxon; and (4) economical—due to the simplicity of the proposed
method, determination of paraoxon can be achieved with most existing flow injection
instrumentation with high sample throughput.
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Table 4. 1 Features of the method
Injection
volume
Equation"
Regression
coefficient
Linear range''
Detection limit''
Quantitative limit''
R.S.D %
500 ^ll
A=(2.76±0.14 )xlO^ [PI + 4.82x104
0.99927
25-25000
5
25
0.7-5.8
50 ^il
A=(5860±130) [Pl + 4.14xl04
0.99935
125-25000
25
125
0.7-7.5
A = area of absorbance at 400 nm, [PI = paraoxon concentration (ng/ml)
'' ng/ml
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Figure 4.1 Flow injection manifold for determination of organophosphate pesticides: C
Carrier stream; P = peristaltic pump; I = injection valve; D =
spectrophotometric detector; W = Waste; and R = Recorder. The enzyme
reactor is constructed from immobilized phosphotriesterase on glass beads
(75 |im diameter).
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Figure 4.2 Spectrophotometric determination of paraoxon by flow injection analysis.
The concentrations of paraoxon are (a) 12.5 |ig/ml, (b) 25 |ig/ml, (c) 50
|ig/ml and (d) 75 |ig/ml. The carrier stream was 50 mM HEPES buffer, pH
8.5. The injection volume was 50 ^il, sampling rate approximately 150 per
hour.
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Figure 4.3 Effect of flow rate on the area of absorbance peaks at paraoxon concentrations
of 25 llg/ml, 12.5 |lg/ml and 5.0 [ig/mi. The injection volume was 50 |J.l.
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Figure 4.4 Effect of flow rate on absorbance at 400 nm for hydrolysis of paraoxon of 25
^ig/ml in 50 mM HEPES, pH 8.5. The flow rates are: 1=3.8 ml/min; 2=3.2
ml/min; 3=2.8 ml/min; 4=2.2 ml/min; 5=1.7 ml/min; 6=1.1 ml/min; 7=0.5
ml/min and 8=0.32 ml/min.
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Figure 4.5 Variation of peak area with sample injection volume. Paraoxon concentration
is 12.5 |ig/ml, flow rate 0.5 ml/min.
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Figure 4.6 Calibration curves for paraoxon with samples ranging from 25 to 25000 ng/ml
using the flow injection device. Samples at each concentration were injected
in triplicate.
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